1 |
(11c)pe2i |
- |
- |
- |
- |
006 [1] 6 💬 |
2 |
(2-chloro-5-[11c]methoxy-n-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide) |
- |
- |
- |
- |
006 [1] 6 💬 |
3 |
(3beta, 5beta, 25r)-spirostan-3-ol |
- |
- |
- |
- |
006 [1] 6 💬 |
4 |
(3ß, 5ß, 25r)-spirostan-3-ol |
- |
- |
- |
- |
006 [1] 6 💬 |
5 |
(6s)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol |
- |
- |
- |
- |
006 [1] 6 💬 |
6 |
(minus)-l-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate |
- |
- |
- |
- |
006 [1] 6 💬 |
7 |
(r)-troloxamide quinone |
- |
- |
- |
- |
006 [1] 6 💬 |
8 |
(s)- 2- amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol |
- |
- |
- |
- |
006 [1] 6 💬 |
9 |
(s)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate |
- |
- |
- |
- |
006 [1] 6 💬 |
10 |
0 mg tropicamide |
Tropicamide |
[1] D00397 D00397 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
11 |
0.04 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
12 |
0.08 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
13 |
0.2 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
14 |
0.3 mg tropicamide |
Tropicamide |
[1] D00397 D00397 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
15 |
0.4 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
16 |
0.6 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
17 |
0.8 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
18 |
0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [4] 6 , 14, 51, 53 💬 |
19 |
0.9% sodium chloride (normal saline) |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [1] 6 💬 |
20 |
00000 |
- |
- |
- |
- |
006 [1] 6 💬 |
21 |
000000 |
- |
- |
- |
- |
006 [1] 6 💬 |
22 |
009-0 |
- |
- |
- |
- |
006 [1] 6 💬 |
23 |
009-1 |
- |
- |
- |
- |
006 [1] 6 💬 |
24 |
009-2 |
- |
- |
- |
- |
006 [1] 6 💬 |
25 |
009-3 |
- |
- |
- |
- |
006 [1] 6 💬 |
26 |
009-4 |
- |
- |
- |
- |
006 [1] 6 💬 |
27 |
009-5 |
- |
- |
- |
- |
006 [1] 6 💬 |
28 |
009-a0 |
- |
- |
- |
- |
006 [1] 6 💬 |
29 |
009-a1 |
- |
- |
- |
- |
006 [1] 6 💬 |
30 |
009-a2 |
- |
- |
- |
- |
006 [1] 6 💬 |
31 |
009-a3 |
- |
- |
- |
- |
006 [1] 6 💬 |
32 |
1 mg qd to 15 mg qd pf-06649751 |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
33 |
1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
34 |
1 mg tropicamide |
Tropicamide |
[1] D00397 D00397 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
35 |
1. tesofensine (ns 2330) |
Tesofensine |
- |
- |
- |
006 [1] 6 💬 |
36 |
1.0 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
37 |
1.0 mg rasagiline mesylate |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
38 |
1.2 mg lu ae04621 |
- |
- |
- |
- |
006 [1] 6 💬 |
39 |
100 |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
40 |
11c-methylreboxetine |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
41 |
11c-pbr28 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
42 |
11c-pib |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
43 |
11c-raclopride |
Raclopride |
- |
- |
- |
006 [1] 6 💬 |
44 |
125 |
- |
- |
- |
- |
006 [1] 6 💬 |
45 |
13n-ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [2] 6 , 17 💬 |
46 |
15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
47 |
15 mg qd pf-06649751 |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
48 |
15o h2o |
- |
- |
- |
- |
006 [1] 6 💬 |
49 |
18-fdtbz |
- |
- |
- |
- |
006 [1] 6 💬 |
50 |
18f florbetaben |
- |
- |
- |
- |
006 [1] 6 💬 |
51 |
18f- dtbz |
- |
- |
- |
- |
006 [1] 6 💬 |
52 |
18f-av-133 |
Florbenazine F-18 |
- |
- |
- |
006 [1] 6 💬 |
53 |
18f-av-45 |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
54 |
18f-dopa |
- |
- |
- |
- |
006 [3] 6 , 17, 75 💬 |
55 |
18f-dopa pet |
- |
- |
- |
- |
006 [1] 6 💬 |
56 |
18f-dopamne |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
57 |
18f-dtbz |
- |
- |
- |
- |
006 [1] 6 💬 |
58 |
18f-dtbz av-133 |
- |
- |
- |
- |
006 [1] 6 💬 |
59 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 [12] 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
60 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
61 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
62 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
63 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
64 |
2 mg perampanel |
Perampanel |
[1] D08964 D08964 💬 |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
006 [1] 6 💬 |
65 |
2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide |
- |
- |
- |
- |
006 [1] 6 💬 |
66 |
2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride |
- |
- |
- |
- |
006 [2] 6 , 162 💬 |
67 |
200 mg bia 6-512 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
68 |
207-3120 |
- |
- |
- |
- |
006 [1] 6 💬 |
69 |
240mg amantadine hcl er tablets |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
70 |
25 mg bia9 1067 |
- |
- |
- |
- |
006 [1] 6 💬 |
71 |
25 mg ongentys |
- |
- |
- |
- |
006 [1] 6 💬 |
72 |
25330 |
- |
- |
- |
- |
006 [1] 6 💬 |
73 |
3 mg qd to 15 mg qd pf-06649751 |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
74 |
3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
75 |
3 mg tropicamide |
Tropicamide |
[1] D00397 D00397 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
76 |
3- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate |
- |
- |
- |
- |
006 [1] 6 💬 |
77 |
3-(3,4-dihydroxyphenyl)-l-alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [1] 6 💬 |
78 |
320mg amantadine hcl er tablets |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
79 |
4 mg perampanel |
Perampanel |
[1] D08964 D08964 💬 |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
006 [1] 6 💬 |
80 |
50 mg bia 9 1067 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
81 |
50 mg ongentys |
- |
- |
- |
- |
006 [1] 6 💬 |
82 |
6abeta - apomorphine-10,11-diol hydrochloride hemihydrate |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
83 |
6aß - apomorphine-10,11-diol hydrochloride hemihydrate |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
84 |
7 mg qd to 15 mg qd pf-06649751 |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
85 |
7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
86 |
7-beta-hydroxyepiandrosterone |
7-beta-Hydroxyepiandrosterone |
- |
- |
- |
006 [1] 6 💬 |
87 |
75 |
- |
- |
- |
- |
006 [1] 6 💬 |
88 |
8-ohdg |
8-hydroxy-2'-deoxyguanosine |
- |
- |
- |
006 [1] 6 💬 |
89 |
[11c]pbr28 |
- |
- |
- |
- |
006 [1] 6 💬 |
90 |
[11c]pxt012253 |
- |
- |
- |
- |
006 [1] 6 💬 |
91 |
[11c]smw139 |
- |
- |
- |
- |
006 [1] 6 💬 |
92 |
[123i] 5-ia |
- |
- |
- |
- |
006 [1] 6 💬 |
93 |
[123i] ibvm and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
94 |
[123i] mzint injection and serial dynamic spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
95 |
[123i]-ibvm |
- |
- |
- |
- |
006 [1] 6 💬 |
96 |
[123i]b-cit |
- |
- |
- |
- |
006 [1] 6 💬 |
97 |
[123i]b-cit spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
98 |
[123i]beta cit |
- |
- |
- |
- |
006 [1] 6 💬 |
99 |
[123i]beta cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
100 |
[123i]beta-cit |
- |
- |
- |
- |
006 [1] 6 💬 |
101 |
[123i]beta-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
102 |
[123i]clinde |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
103 |
[123i]mni-420 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
104 |
[123i]ß cit |
- |
- |
- |
- |
006 [1] 6 💬 |
105 |
[123i]ß cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
106 |
[123i]ß-cit |
- |
- |
- |
- |
006 [1] 6 💬 |
107 |
[123i]ß-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
108 |
[14c]-bia 9-1067 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
109 |
[15o]h2o |
- |
- |
- |
- |
006 [1] 6 💬 |
110 |
[18f] cfpypb |
- |
- |
- |
- |
006 [1] 6 💬 |
111 |
[18f] lbt-999 |
- |
- |
- |
- |
006 [1] 6 💬 |
112 |
[18f] lbt-999 pet |
- |
- |
- |
- |
006 [1] 6 💬 |
113 |
[18f] pbr06 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
114 |
[18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane |
- |
- |
- |
- |
006 [1] 6 💬 |
115 |
[18f]-feppa |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
116 |
[18f]dpa-714 pet scan |
- |
- |
- |
- |
006 [1] 6 💬 |
117 |
[18f]fdopa |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
118 |
[18f]fdopa pet/ct |
- |
- |
- |
- |
006 [1] 6 💬 |
119 |
[18f]fe-pe2i |
- |
- |
- |
- |
006 [1] 6 💬 |
120 |
[18f]fpeb |
- |
- |
- |
- |
006 [3] 6 , 8 , 206 💬 |
121 |
[18f]mk-9470 |
- |
- |
- |
- |
006 [1] 6 💬 |
122 |
[18f]mni-1126 |
- |
- |
- |
- |
006 [1] 6 💬 |
123 |
[18f]mppf |
- |
- |
- |
- |
006 [1] 6 💬 |
124 |
[18f]nos |
- |
- |
- |
- |
006 [1] 6 💬 |
125 |
[18f]p17-059 |
- |
- |
- |
- |
006 [1] 6 💬 |
126 |
[18f]pi-2620 |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
127 |
[18f]t807 ([18f]mni-777) |
- |
- |
- |
- |
005 [2] 5 , 6 💬 |
128 |
[21cfr640.30] plasma from 18 - 25 year old volunteer donors |
- |
- |
- |
- |
006 [1] 6 💬 |
129 |
[abbv-951] |
- |
- |
- |
- |
006 [1] 6 💬 |
130 |
[f-18] fluorodopa positron emission tomography |
- |
- |
- |
- |
006 [1] 6 💬 |
131 |
[jnj31-31001074] |
- |
- |
- |
- |
006 [1] 6 💬 |
132 |
[na] |
- |
- |
- |
- |
006 [7] 6 , 11, 35, 46, 53, 65, 299 💬 |
133 |
A-dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
134 |
Aav2-gdnf |
- |
- |
- |
- |
006 [1] 6 💬 |
135 |
Ab1010 |
- |
- |
- |
- |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
136 |
Abbv-0805 |
- |
- |
- |
- |
006 [1] 6 💬 |
137 |
Abbv-951 |
- |
- |
- |
- |
006 [1] 6 💬 |
138 |
Abt-slv187 |
- |
- |
- |
- |
006 [1] 6 💬 |
139 |
Acamprosate |
Acamprosate |
[2] D02780 D02780, D07058 D07058 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [2] 6 , 206 💬 |
140 |
Accordion pill carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
141 |
Accordion pill ¿ carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
142 |
Accordion pill ¿ carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
143 |
Accordion pill? carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
144 |
Accordion pill? carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
145 |
Accordion pill™ carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
146 |
Accordion pill™ carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
147 |
Accordion pill™ carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
148 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
149 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
150 |
Acp-103 |
- |
- |
- |
- |
006 [1] 6 💬 |
151 |
Acr325 |
ACR325 |
- |
- |
- |
006 [1] 6 💬 |
152 |
Active comparator |
- |
- |
- |
- |
006 [2] 6 , 46 💬 |
153 |
Active drug (biib014) at 10, 30, 100, or 300 mg once daily. |
- |
- |
- |
- |
006 [1] 6 💬 |
154 |
Active drug: pimavanserin 17mg (2 strength tablets) |
Pimavanserin |
- |
- |
- |
006 [1] 6 💬 |
155 |
Active investigational treatment ent-01 |
- |
- |
- |
- |
006 [1] 6 💬 |
156 |
Ad-810n (zonisamide) |
Zonisamide |
[1] D00538 D00538 💬 |
CACNA1G [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 [1] 6 💬 |
157 |
Adjuvant without active component |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
158 |
Administration of stable isotope-labelled leucine- |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
006 [1] 6 💬 |
159 |
Ads-5102 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
160 |
Ads-5102 (extended release amantadine hcl) |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
161 |
Adx48621 |
- |
- |
- |
- |
006 [1] 6 💬 |
162 |
Affitope® pd01a |
- |
- |
- |
- |
006 [1] 6 💬 |
163 |
Affitope® pd01a + adjuvant |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
164 |
Afq056 |
- |
- |
- |
- |
006 [3] 6 , 8 , 206 💬 |
165 |
Afq056 with l-dopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
166 |
Afq065 |
- |
- |
- |
- |
006 [1] 6 💬 |
167 |
Agomelatine |
Agomelatine |
[1] D02578 D02578 💬 |
HTR2C [3] HTR2C, MTNR1A, MTNR1B 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 [1] 6 💬 |
168 |
Agomelatine or piacebo |
Agomelatine |
[1] D02578 D02578 💬 |
HTR2C [3] HTR2C, MTNR1A, MTNR1B 💬 |
Calcium signaling pathway [6] Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 [1] 6 💬 |
169 |
Aha |
- |
- |
- |
- |
006 [1] 6 💬 |
170 |
Akst4290 |
- |
- |
- |
- |
006 [2] 6 , 162 💬 |
171 |
Al |
- |
- |
- |
- |
005 [9] 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
172 |
Alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [4] 6 , 13, 298, 299 💬 |
173 |
Allogeneic bone marrow-derived mscs (1 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
174 |
Allogeneic bone marrow-derived mscs (10 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
175 |
Allogeneic bone marrow-derived mscs (3 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
176 |
Allogeneic bone marrow-derived mscs (6 x 10 6 msc/kg) |
- |
- |
- |
- |
006 [1] 6 💬 |
177 |
Allopurinol |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 [6] 6 , 46, 57, 66, 96, 97 💬 |
178 |
Altropane |
Altropane |
- |
- |
- |
006 [1] 6 💬 |
179 |
Altropane® |
Altropane |
- |
- |
- |
006 [1] 6 💬 |
180 |
Amantadin-ratiopharm 100mg |
- |
- |
- |
- |
006 [1] 6 💬 |
181 |
Amantadine |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [4] 6 , 8 , 13, 127 💬 |
182 |
Amantadine 300 mg |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
183 |
Amantadine hcl er |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
184 |
Amantadine hcl extended release |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
185 |
Amantadine hcl extended release capsule |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
186 |
Amantadine hydrochloride |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
187 |
Amantadine hydrochloride (hcl) |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
188 |
Amantadine sulfate |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
189 |
Ambrosan 60mg tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
190 |
Ambroxol |
Ambroxol |
[1] D07442 D07442 💬 |
- |
- |
006 [2] 6 , 19 💬 |
191 |
Ambroxol hydrochloride |
Ambroxol |
[1] D07442 D07442 💬 |
- |
- |
006 [1] 6 💬 |
192 |
Ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [4] 6 , 17, 86, 88 💬 |
193 |
Amoxicillin |
Amoxicillin |
[3] D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 [7] 6 , 46, 63, 96, 97, 222, 299 💬 |
194 |
Ampreloxetine |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
195 |
Ampreloxetine chydrochloride |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
196 |
Ampreloxetine hydrochloride |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
197 |
Ampyra |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
198 |
Ampyra first, |
- |
- |
- |
- |
006 [1] 6 💬 |
199 |
Anavex2-73 |
- |
- |
- |
- |
006 [2] 6 , 156 💬 |
200 |
Anhydrous carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
201 |
Anti-parkinson medication |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
202 |
Antiparkinsonian agent(s) |
- |
- |
- |
- |
006 [1] 6 💬 |
203 |
Ap |
- |
- |
- |
- |
002 [4] 2 , 6 , 13, 299 💬 |
204 |
Ap-cd/ld |
- |
- |
- |
- |
006 [1] 6 💬 |
205 |
Ap09004 |
- |
- |
- |
- |
006 [1] 6 💬 |
206 |
Apl-130277 |
- |
- |
- |
- |
006 [1] 6 💬 |
207 |
Aplindore |
Aplindore |
- |
- |
- |
006 [1] 6 💬 |
208 |
Aplindore mr tablets |
Aplindore |
- |
- |
- |
006 [1] 6 💬 |
209 |
Apo-go |
- |
- |
- |
- |
006 [1] 6 💬 |
210 |
Apo-go® |
- |
- |
- |
- |
006 [1] 6 💬 |
211 |
Apokinon |
- |
- |
- |
- |
006 [1] 6 💬 |
212 |
Apokyn |
- |
- |
- |
- |
006 [1] 6 💬 |
213 |
Apomor |
- |
- |
- |
- |
006 [1] 6 💬 |
214 |
Apomorp |
- |
- |
- |
- |
006 [1] 6 💬 |
215 |
Apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
216 |
Apomorphine 0.25% (2.5mg/ml) |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
217 |
Apomorphine hcl injection |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
218 |
Apomorphine hydrochloride |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
219 |
Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
220 |
Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
221 |
Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
222 |
Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
223 |
Apomorphine hydrochloride hemihydrate |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
224 |
Apomorphine hydrocloride |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
225 |
Apomorphine hydrocloride hemihydrate |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
226 |
Apomorphine infusion |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
227 |
Apomorphine nasal powder |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
228 |
Aporon |
- |
- |
- |
- |
006 [1] 6 💬 |
229 |
Aqw051 |
- |
- |
- |
- |
006 [1] 6 💬 |
230 |
Aricept |
- |
- |
- |
- |
006 [4] 6 , 13, 78, 124 💬 |
231 |
Aricept 5 mg-filmtabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
232 |
Aricept 5mg-filmtabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
233 |
Aripiprazole |
Aripiprazole |
[1] D01164 D01164 💬 |
DRD2 [4] DRD2, DRD3, HTR1A, HTR2A 💬 |
Alcoholism [12] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 206 💬 |
234 |
Armodafinil |
Armodafinil |
[1] D03215 D03215 💬 |
SLC6A3 [1] SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [3] 6 , 13, 84 💬 |
235 |
Artane |
- |
- |
- |
- |
006 [1] 6 💬 |
236 |
As2 |
- |
- |
- |
- |
006 [1] 6 💬 |
237 |
Asyn mab |
- |
- |
- |
- |
006 [1] 6 💬 |
238 |
At 10 |
- |
- |
- |
- |
006 [1] 6 💬 |
239 |
Atm fog in pd |
- |
- |
- |
- |
006 [1] 6 💬 |
240 |
Atomoxetine |
Atomoxetine |
[2] D02574 D02574, D07473 D07473 💬 |
SLC6A2 [1] SLC6A2 💬 |
Synaptic vesicle cycle [1] Synaptic vesicle cycle |
006 [3] 6 , 8 , 13 💬 |
241 |
Atypical antipsychotics |
- |
- |
- |
- |
006 [1] 6 💬 |
242 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 [5] 2 , 6 , 13, 17, 46 💬 |
243 |
Av-101 |
AV-101 |
- |
- |
- |
006 [1] 6 💬 |
244 |
Avalox |
- |
- |
- |
- |
006 [1] 6 💬 |
245 |
Avalox - 400 mg compresse rivestite con film 5 compresse in blister pp/al |
- |
- |
- |
- |
006 [1] 6 💬 |
246 |
Ave8112 |
- |
- |
- |
- |
006 [1] 6 💬 |
247 |
Avp-923 |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
248 |
Avp-923-45 |
- |
- |
- |
- |
006 [1] 6 💬 |
249 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
250 |
Azd3241 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
251 |
Azd3241 300 mg bid |
- |
- |
- |
- |
006 [1] 6 💬 |
252 |
Azd3241 600 mg bid |
- |
- |
- |
- |
006 [1] 6 💬 |
253 |
Azd3241 alternative titration scheme with formulation 1 or 2 |
- |
- |
- |
- |
006 [1] 6 💬 |
254 |
Azd3241 er formulation 1 |
- |
- |
- |
- |
006 [1] 6 💬 |
255 |
Azd3241 extended release tablets 100 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
256 |
Azd3241 extended release tablets 25 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
257 |
Azilect |
- |
- |
- |
- |
002 [4] 2 , 5 , 6 , 17 💬 |
258 |
Azilect 1 mg comprimidos |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
259 |
Azilect 1mg |
- |
- |
- |
- |
006 [1] 6 💬 |
260 |
Azilect® |
- |
- |
- |
- |
006 [1] 6 💬 |
261 |
B-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
262 |
B6, b12, l-methylfolate |
Levomefolic acid |
[1] D09353 D09353 💬 |
- |
- |
006 [1] 6 💬 |
263 |
Balance |
Isoxaflutole |
- |
- |
- |
005 [9] 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
264 |
Band |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
265 |
Bavisant |
Bavisant |
[1] D09870 D09870 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
266 |
Bavisant dihydrochloride monohydrate |
Bavisant |
[1] D09870 D09870 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
267 |
Bavisant hydrochloride monohydrate |
Bavisant |
[1] D09870 D09870 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
268 |
Beam |
Tricyclazole |
- |
- |
- |
006 [2] 6 , 51 💬 |
269 |
Bee venom |
- |
- |
- |
- |
006 [1] 6 💬 |
270 |
Behavioral: assessment of cognition |
- |
- |
- |
- |
006 [1] 6 💬 |
271 |
Behavioral: assessment of depression |
- |
- |
- |
- |
006 [1] 6 💬 |
272 |
Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors |
- |
- |
- |
- |
006 [1] 6 💬 |
273 |
Behavioral: assessment of quality of life |
- |
- |
- |
- |
006 [1] 6 💬 |
274 |
Behavioral: assessment of severity of icd (impulse control disorders) |
- |
- |
- |
- |
006 [1] 6 💬 |
275 |
Behavioral: assessment of severity of parkinson disease |
- |
- |
- |
- |
006 [1] 6 💬 |
276 |
Behavioral: attention control |
- |
- |
- |
- |
006 [1] 6 💬 |
277 |
Behavioral: augmented reality multi-modal training |
- |
- |
- |
- |
006 [1] 6 💬 |
278 |
Behavioral: balance & strengthening exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
279 |
Behavioral: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
280 |
Behavioral: bci-fit active querying |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
281 |
Behavioral: bci-fit adaptive signal modeling |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
282 |
Behavioral: bci-fit language modeling |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
283 |
Behavioral: bci-fit multi-modal access |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
284 |
Behavioral: brisk walking and balance training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
285 |
Behavioral: building better caregivers workshop |
- |
- |
- |
- |
006 [1] 6 💬 |
286 |
Behavioral: cbt and sleep hygiene |
- |
- |
- |
- |
006 [1] 6 💬 |
287 |
Behavioral: co-op treatment protocol |
- |
- |
- |
- |
006 [1] 6 💬 |
288 |
Behavioral: cognitive and behavioral experimental tasks |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
289 |
Behavioral: combined balance and brisk walking training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
290 |
Behavioral: conservative measures for orthostatic hypotension |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
291 |
Behavioral: dexterity |
- |
- |
- |
- |
006 [1] 6 💬 |
292 |
Behavioral: dual task |
- |
- |
- |
- |
006 [1] 6 💬 |
293 |
Behavioral: ecocapture |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
294 |
Behavioral: emotion assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
295 |
Behavioral: exercise |
- |
- |
- |
- |
006 [3] 6 , 265, 299 💬 |
296 |
Behavioral: exercise only |
- |
- |
- |
- |
006 [1] 6 💬 |
297 |
Behavioral: exercise+multi-modal sensory feedback (mmsf) |
- |
- |
- |
- |
006 [1] 6 💬 |
298 |
Behavioral: flexibility and strengthening exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
299 |
Behavioral: gait and balance |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
300 |
Behavioral: gait and balance training program |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
301 |
Behavioral: healthy age-matched controls |
- |
- |
- |
- |
006 [1] 6 💬 |
302 |
Behavioral: icm_apathy_tasks |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
303 |
Behavioral: levodopa or acupuncture |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
304 |
Behavioral: low-impact exercise control |
- |
- |
- |
- |
006 [1] 6 💬 |
305 |
Behavioral: memory |
- |
- |
- |
- |
006 [1] 6 💬 |
306 |
Behavioral: participant open-response writing |
- |
- |
- |
- |
006 [1] 6 💬 |
307 |
Behavioral: participant self-assessment surveys |
- |
- |
- |
- |
006 [1] 6 💬 |
308 |
Behavioral: pat sessions |
- |
- |
- |
- |
006 [1] 6 💬 |
309 |
Behavioral: pelvic floor muscle exercise-based behavioral therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
310 |
Behavioral: phonation |
- |
- |
- |
- |
006 [1] 6 💬 |
311 |
Behavioral: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
312 |
Behavioral: physical therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
313 |
Behavioral: resistance training |
- |
- |
- |
- |
006 [1] 6 💬 |
314 |
Behavioral: rest |
- |
- |
- |
- |
006 [1] 6 💬 |
315 |
Behavioral: role of dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
316 |
Behavioral: single task |
- |
- |
- |
- |
006 [1] 6 💬 |
317 |
Behavioral: strength training |
- |
- |
- |
- |
006 [1] 6 💬 |
318 |
Behavioral: stretching |
- |
- |
- |
- |
006 [1] 6 💬 |
319 |
Behavioral: tai chi |
- |
- |
- |
- |
006 [1] 6 💬 |
320 |
Behavioral: traditional multi-modal training |
- |
- |
- |
- |
006 [1] 6 💬 |
321 |
Behavioral: upper limb exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
322 |
Ben-2001 |
- |
- |
- |
- |
006 [1] 6 💬 |
323 |
Benserazide |
Benserazide |
[1] D03082 D03082 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
324 |
Benserazide hydrochloride |
Benserazide |
[1] D03082 D03082 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
325 |
Benzofuran |
Benzofuran |
- |
- |
- |
006 [1] 6 💬 |
326 |
Berachin |
- |
- |
- |
- |
006 [1] 6 💬 |
327 |
Best medical treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
328 |
Best médical treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
329 |
Betaquik mct supplement |
- |
- |
- |
- |
006 [1] 6 💬 |
330 |
Better |
- |
- |
- |
- |
006 [1] 6 💬 |
331 |
Bf 2.649 |
- |
- |
- |
- |
006 [1] 6 💬 |
332 |
Bf 2.649 10 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
333 |
Bf 2.649 20 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
334 |
Bf 2.649 40 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
335 |
Bf 2.649 5 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
336 |
Bf2.649 |
- |
- |
- |
- |
006 [1] 6 💬 |
337 |
Bf2.649 (pitolisant) |
Pitolisant |
[1] D10749 D10749 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
338 |
Bi-sifrol® |
- |
- |
- |
- |
006 [1] 6 💬 |
339 |
Bia |
BIA |
- |
- |
- |
006 [2] 6 , 86 💬 |
340 |
Bia 3-202 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
341 |
Bia 3-202 (200 mg) |
BIA |
- |
- |
- |
006 [1] 6 💬 |
342 |
Bia 6-512 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
343 |
Bia 6-512 100 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
344 |
Bia 6-512 100 mg dose |
BIA |
- |
- |
- |
006 [1] 6 💬 |
345 |
Bia 6-512 200 mg dose |
BIA |
- |
- |
- |
006 [1] 6 💬 |
346 |
Bia 6-512 25 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
347 |
Bia 6-512 25 mg dose |
BIA |
- |
- |
- |
006 [1] 6 💬 |
348 |
Bia 6-512 400 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
349 |
Bia 6-512 50 mg dose |
BIA |
- |
- |
- |
006 [1] 6 💬 |
350 |
Bia 9-1067 |
BIA |
- |
- |
- |
006 [1] 6 💬 |
351 |
Bia 9-1067 (test) |
BIA |
- |
- |
- |
006 [1] 6 💬 |
352 |
Bia 9-1067 15 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
353 |
Bia 9-1067 25 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
354 |
Bia 9-1067 30 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
355 |
Bia 9-1067 5 mg |
BIA |
- |
- |
- |
006 [1] 6 💬 |
356 |
Bia 9-1067 micronized |
BIA |
- |
- |
- |
006 [1] 6 💬 |
357 |
Bia 9-1067 non-micronized |
BIA |
- |
- |
- |
006 [1] 6 💬 |
358 |
Biib014 |
- |
- |
- |
- |
006 [1] 6 💬 |
359 |
Biib054 |
- |
- |
- |
- |
006 [1] 6 💬 |
360 |
Biib094 |
- |
- |
- |
- |
006 [1] 6 💬 |
361 |
Bisphosphonates |
- |
- |
- |
- |
006 [2] 6 , 274 💬 |
362 |
Bone marrow derived mesenchymal stem cells |
- |
- |
- |
- |
006 [2] 6 , 60 💬 |
363 |
Bont-a |
- |
- |
- |
- |
006 [1] 6 💬 |
364 |
Botox |
- |
- |
- |
- |
002 [6] 2 , 6 , 13, 51, 149, 226 💬 |
365 |
Botulinum toxin |
- |
- |
- |
- |
006 [3] 6 , 13, 149 💬 |
366 |
Botulinum toxin type a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [10] 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
367 |
Botulinum toxin type b |
Botulinum Toxin Type B |
[1] D02735 D02735 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [3] 2 , 6 , 51 💬 |
368 |
Botulinum toxin type b (myobloc) |
Botulinum Toxin Type B |
[1] D02735 D02735 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [2] 2 , 6 💬 |
369 |
Botulinum toxin: xeomin |
- |
- |
- |
- |
006 [1] 6 💬 |
370 |
Bromocriptine |
Bromocriptine |
[2] D00780 D00780, D03165 D03165 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 74 💬 |
371 |
Bromocriptine and other dopamine agonists |
Bromocriptine |
[4] D00633 D00633, D00780 D00780, D03165 D03165, D07870 D07870 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 |
Alcoholism [15] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
372 |
Btrx-246040 |
BTRX-246040 |
- |
- |
- |
006 [1] 6 💬 |
373 |
Btx-a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [1] 6 💬 |
374 |
Bumetanide |
Bumetanide |
[1] D00247 D00247 💬 |
SLC12A2 [1] SLC12A2 💬 |
Pancreatic secretion [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection |
006 [2] 6 , 158 💬 |
375 |
Bumetanide white, oblong, scored tablet |
Bumetanide |
[1] D00247 D00247 💬 |
SLC12A2 [1] SLC12A2 💬 |
Pancreatic secretion [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection |
006 [1] 6 💬 |
376 |
Bupleurum+ginkgo |
Ginkgo biloba |
- |
- |
- |
006 [1] 6 💬 |
377 |
Buspirone |
Buspirone |
[2] D00702 D00702, D07593 D07593 💬 |
DRD2 [2] DRD2, HTR1A 💬 |
Alcoholism [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 51 💬 |
378 |
Buspirone hydrochloride |
Buspirone |
[2] D00702 D00702, D07593 D07593 💬 |
DRD2 [2] DRD2, HTR1A 💬 |
Alcoholism [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
379 |
Butylphthalide |
Butylphthalide |
- |
- |
- |
002 [4] 2 , 6 , 18, 22 💬 |
380 |
Bydureon |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
381 |
Bydureon 2 mg powder and solvent for prolonged-release suspension |
- |
- |
- |
- |
006 [1] 6 💬 |
382 |
Byetta |
- |
- |
- |
- |
006 [2] 6 , 193 💬 |
383 |
Byetta 5 micrograms |
- |
- |
- |
- |
006 [1] 6 💬 |
384 |
Cabaser |
- |
- |
- |
- |
006 [1] 6 💬 |
385 |
Cabaseril |
- |
- |
- |
- |
006 [1] 6 💬 |
386 |
Cabaseril, 1,0 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
387 |
Cabaseril, 2,0 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
388 |
Cabergolina |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
389 |
Cabergoline |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 75 💬 |
390 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
391 |
Caffeine 100-200 mg bid |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
392 |
Caffeine alkaloid |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
393 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
394 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
395 |
Cannabidiol (cbd) |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [6] 6 , 140, 144, 145, 156, 158 💬 |
396 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
397 |
Cannabis oil |
Medical Cannabis |
- |
- |
- |
006 [1] 6 💬 |
398 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 [5] 2 , 6 , 13, 96, 97 💬 |
399 |
Capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [5] 2 , 6 , 19, 86, 226 💬 |
400 |
Capsaicin vapor |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
401 |
Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
402 |
Capture |
Bifenthrin |
- |
- |
- |
006 [2] 6 , 46 💬 |
403 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
404 |
Carbidopa (fu) |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
405 |
Carbidopa 20 mg |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
406 |
Carbidopa 200mg oral dose |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
407 |
Carbidopa 27.5 mg |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
408 |
Carbidopa 65 mg capsule |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
409 |
Carbidopa and levodopa 25mg/100mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
410 |
Carbidopa and levodopa tablets, usp |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
411 |
Carbidopa anidra |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
412 |
Carbidopa fu |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
413 |
Carbidopa inn |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
414 |
Carbidopa levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
415 |
Carbidopa monohydrate |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
416 |
Carbidopa, levodopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
417 |
Carbidopa- levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
418 |
Carbidopa-4'-monophosphate |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
419 |
Carbidopa-levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
002 [3] 2 , 4 , 6 💬 |
420 |
Carbidopa-levodopa 25 mg-100 mg oral tablet |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
421 |
Carbidopa/l-dopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
422 |
Carbidopa/l-dopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
423 |
Carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
424 |
Carbidopa/levodopa, immediate release |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
425 |
Carbidopa/levodopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
426 |
Carbidopamonohydraat |
- |
- |
- |
- |
006 [1] 6 💬 |
427 |
Carbodopa levadopa |
- |
- |
- |
- |
006 [1] 6 💬 |
428 |
Carbodopa/levadopa |
- |
- |
- |
- |
006 [1] 6 💬 |
429 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
430 |
Carnosine |
Carnosine |
- |
- |
- |
006 [2] 6 , 13 💬 |
431 |
Carnosine supplementation |
Carnosine |
- |
- |
- |
006 [1] 6 💬 |
432 |
Carvedilol |
Carvedilol |
[2] D00255 D00255, D03415 D03415 💬 |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 57, 86, 113, 210 💬 |
433 |
Catapres ampoules |
- |
- |
- |
- |
006 [1] 6 💬 |
434 |
Catapressan |
- |
- |
- |
- |
006 [1] 6 💬 |
435 |
Cbd |
- |
- |
- |
- |
002 [11] 2 , 6 , 8 , 13, 46, 140, 144, 145, 156, 158, 206 💬 |
436 |
Cd |
- |
- |
- |
- |
006 [6] 6 , 46, 51, 96, 97, 265 💬 |
437 |
Cd-ld cr |
- |
- |
- |
- |
006 [1] 6 💬 |
438 |
Cd-ld ir |
- |
- |
- |
- |
006 [1] 6 💬 |
439 |
Cdnf |
- |
- |
- |
- |
006 [1] 6 💬 |
440 |
Ceftriaxone |
Ceftriaxone |
[2] D00924 D00924, D07659 D07659 💬 |
- |
- |
002 [3] 2 , 6 , 97 💬 |
441 |
Cep-1347 |
CEP-1347 |
- |
- |
- |
006 [1] 6 💬 |
442 |
Cep-1347 10mg |
CEP-1347 |
- |
- |
- |
006 [1] 6 💬 |
443 |
Cep-1347 50mg |
CEP-1347 |
- |
- |
- |
006 [1] 6 💬 |
444 |
Cep1347 |
- |
- |
- |
- |
006 [1] 6 💬 |
445 |
Cep1347 25mg |
- |
- |
- |
- |
006 [1] 6 💬 |
446 |
Cere-120 |
- |
- |
- |
- |
006 [1] 6 💬 |
447 |
Cere-120 (adeno-associated virus serotype 2 [aav2]-neurturin [ntn]) |
- |
- |
- |
- |
006 [1] 6 💬 |
448 |
Cere-120: adeno-associated virus delivery of neurturin |
- |
- |
- |
- |
006 [1] 6 💬 |
449 |
Cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
450 |
Ceretec |
- |
- |
- |
- |
006 [1] 6 💬 |
451 |
Ceretec (tm) estabilizado |
- |
- |
- |
- |
006 [1] 6 💬 |
452 |
Champix |
- |
- |
- |
- |
006 [1] 6 💬 |
453 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
454 |
Chocolate |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
455 |
Cipralex |
- |
- |
- |
- |
006 [1] 6 💬 |
456 |
Circadin |
- |
- |
- |
- |
006 [3] 6 , 13, 90 💬 |
457 |
Circadin® |
- |
- |
- |
- |
006 [1] 6 💬 |
458 |
Citalopram |
Citalopram |
[2] D00822 D00822, D07704 D07704 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [6] 6 , 8 , 13, 18, 46, 127 💬 |
459 |
Citalopram 20mg |
Citalopram |
[2] D00822 D00822, D07704 D07704 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
460 |
Cjh1 (clr4001) |
- |
- |
- |
- |
006 [1] 6 💬 |
461 |
Clarithromycin |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [8] 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
462 |
Clarithromycin (not used as of 4/2020) |
Clarithromycin |
[1] D00276 D00276 💬 |
- |
- |
006 [1] 6 💬 |
463 |
Clarium 50 mg retardtabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
464 |
Clartihromycin, amoxicillin, and omeprazole |
Amoxicillin |
[7] D00229 D00229, D00455 D00455, D01207 D01207, D02925 D02925, D05259 D05259, D05261 D05261, D07452 D07452 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [1] 6 💬 |
465 |
Cle |
- |
- |
- |
- |
006 [1] 6 💬 |
466 |
Clenbuterol |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
001 [4] 1 , 2 , 6 , 256 💬 |
467 |
Clenbuterol hcl |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
468 |
Clenbuterol hydrochloride |
Clenbuterol |
[1] D07713 D07713 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
469 |
Clonazepam |
Clonazepam |
[1] D00280 D00280 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
470 |
Clonidine |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
471 |
Clonidine hydrochloride |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
472 |
Clozapine |
Clozapine |
[1] D00283 D00283 💬 |
ADRA2A [11] ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Calcium signaling pathway [8] Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
473 |
Co |
- |
- |
- |
- |
006 [5] 6 , 13, 53, 70, 85 💬 |
474 |
Cocoa |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
475 |
Coenzyme q10 |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
002 [12] 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
476 |
Coenzyme q10 nanodispersion (nanoquinone) |
Ubidecarenone |
[1] D01065 D01065 💬 |
- |
- |
006 [1] 6 💬 |
477 |
Coenzyme q10 with vitamin e |
Ubidecarenone |
[2] D01065 D01065, D02331 D02331 💬 |
- |
- |
006 [1] 6 💬 |
478 |
Cofactor |
- |
- |
- |
- |
006 [3] 6 , 265, 288 💬 |
479 |
Cogane |
- |
- |
- |
- |
006 [1] 6 💬 |
480 |
Cogane™ (pym50028) |
- |
- |
- |
- |
006 [1] 6 💬 |
481 |
Cohort 1:nilotinib oral capsules (150mg or 300mg) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
482 |
Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
483 |
Combination injection of epo and g-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 [1] 6 💬 |
484 |
Combination product: l-dopa 140 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
485 |
Combination product: l-dopa 35 mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
486 |
Combination product: l-dopa 70mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
487 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
488 |
Combination product: nd0612 solution for sc infusion |
- |
- |
- |
- |
006 [1] 6 💬 |
489 |
Comparator: carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
490 |
Comparator: levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
491 |
Comtan |
- |
- |
- |
- |
006 [1] 6 💬 |
492 |
Comtan 200* 60 cpr 200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
493 |
Comtan® |
- |
- |
- |
- |
006 [1] 6 💬 |
494 |
Comtanâ® |
- |
- |
- |
- |
006 [1] 6 💬 |
495 |
Comtess |
- |
- |
- |
- |
006 [1] 6 💬 |
496 |
Comtess® |
- |
- |
- |
- |
006 [1] 6 💬 |
497 |
Continuous apomorphine infusion |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
498 |
Continuous intrajejunal infusion of levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
499 |
Continuous release dopamine agonists |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
500 |
Continuous subcutaneous lisuride infusion |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
501 |
Control |
- |
- |
- |
- |
006 [4] 6 , 46, 168, 299 💬 |
502 |
Controlled-release levodopa / carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
503 |
Coq10 |
- |
- |
- |
- |
005 [3] 5 , 6 , 8 💬 |
504 |
Cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 [2] 2 , 6 💬 |
505 |
Cortef |
- |
- |
- |
- |
006 [3] 6 , 81, 83 💬 |
506 |
Cp |
- |
- |
- |
- |
006 [6] 6 , 46, 96, 97, 107, 271 💬 |
507 |
Creatine |
Creatine |
- |
- |
- |
001 [12] 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
508 |
Cst-103 |
- |
- |
- |
- |
006 [1] 6 💬 |
509 |
Cst-139 |
- |
- |
- |
- |
006 [1] 6 💬 |
510 |
Cu(ii)atsm |
- |
- |
- |
- |
002 [2] 2 , 6 💬 |
511 |
Cvd00118-e |
- |
- |
- |
- |
006 [1] 6 💬 |
512 |
Cvl-751 |
- |
- |
- |
- |
006 [1] 6 💬 |
513 |
Cvn424 high dose |
- |
- |
- |
- |
006 [1] 6 💬 |
514 |
Cvn424 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
515 |
Cvt-301 |
- |
- |
- |
- |
006 [1] 6 💬 |
516 |
Cvt-301 (dose level 1) |
- |
- |
- |
- |
006 [1] 6 💬 |
517 |
Cvt-301 (dose level 2) |
- |
- |
- |
- |
006 [1] 6 💬 |
518 |
Cvt-301 35mg |
- |
- |
- |
- |
006 [1] 6 💬 |
519 |
Cvt-301 50mg |
- |
- |
- |
- |
006 [1] 6 💬 |
520 |
Cvt-301 high dose |
- |
- |
- |
- |
006 [1] 6 💬 |
521 |
Cvt-301 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
522 |
Cvt-301, lip |
- |
- |
- |
- |
006 [1] 6 💬 |
523 |
Cvxl-0107 |
- |
- |
- |
- |
006 [1] 6 💬 |
524 |
Cx-8998 |
- |
- |
- |
- |
006 [1] 6 💬 |
525 |
Cyberknife |
- |
- |
- |
- |
006 [1] 6 💬 |
526 |
Cymbalta |
- |
- |
- |
- |
006 [3] 6 , 13, 49 💬 |
527 |
Cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [11] 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
528 |
Cystoscopic injection of botox into the urinary bladder |
- |
- |
- |
- |
006 [1] 6 💬 |
529 |
D-serine |
D-Serine |
[1] D00016 D00016 💬 |
- |
- |
006 [1] 6 💬 |
530 |
D-serine (~2g/day) |
D-Serine |
[1] D00016 D00016 💬 |
- |
- |
006 [1] 6 💬 |
531 |
Da-9701 |
- |
- |
- |
- |
006 [1] 6 💬 |
532 |
Da-9805 45mg |
- |
- |
- |
- |
006 [1] 6 💬 |
533 |
Da-9805 90mg |
- |
- |
- |
- |
006 [1] 6 💬 |
534 |
Daaoi-p |
- |
- |
- |
- |
006 [1] 6 💬 |
535 |
Dacepton 5 mg/ml |
- |
- |
- |
- |
006 [1] 6 💬 |
536 |
Dacepton 5 mg/ml infuusioneste, liuos |
- |
- |
- |
- |
006 [1] 6 💬 |
537 |
Daily ingestion of lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
006 [1] 6 💬 |
538 |
Darifenacin |
Darifenacin |
[2] D01699 D01699, D03654 D03654 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 [2] 6 , 13 💬 |
539 |
Dark chocolate (85% cocoa) |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
540 |
Datscan |
- |
- |
- |
- |
002 [4] 2 , 5 , 6 , 17 💬 |
541 |
Datscan 74 mbq/ml solution for injection |
- |
- |
- |
- |
006 [1] 6 💬 |
542 |
Datscan™ |
- |
- |
- |
- |
006 [1] 6 💬 |
543 |
Datscan™ ioflupane (123i) injection |
- |
- |
- |
- |
005 [3] 5 , 6 , 17 💬 |
544 |
Dc158am |
- |
- |
- |
- |
006 [1] 6 💬 |
545 |
Dci |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
546 |
Dcs |
- |
- |
- |
- |
006 [1] 6 💬 |
547 |
Deanol |
Deanol |
[1] D07777 D07777 💬 |
- |
- |
006 [1] 6 💬 |
548 |
Deanol pyroglutamate |
Deanol |
[1] D07777 D07777 💬 |
- |
- |
006 [1] 6 💬 |
549 |
Debrumyl |
- |
- |
- |
- |
006 [1] 6 💬 |
550 |
Deferiprone |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
002 [6] 2 , 6 , 18, 120, 122, 233 💬 |
551 |
Deferiprone (ferriprox) |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
552 |
Deferiprone 20mg |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
553 |
Deferiprone 30mg |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
554 |
Deferiprone 600 mg delayed release tablet |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
555 |
Deferiprone dr |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
556 |
Desipramine |
Desipramine |
[2] D00812 D00812, D07791 D07791 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [4] 6 , 17, 120, 156 💬 |
557 |
Desipramine (dmi) |
Desipramine |
[2] D00812 D00812, D07791 D07791 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
558 |
Desmopressin |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
006 [5] 6 , 64, 72, 225, 288 💬 |
559 |
Desmopressin acetat |
Desmopressin |
[2] D00291 D00291, D02235 D02235 💬 |
AVPR2 [2] AVPR2, F8 💬 |
Complement and coagulation cascades [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
006 [1] 6 💬 |
560 |
Desmotabs |
- |
- |
- |
- |
006 [1] 6 💬 |
561 |
Desmotabs® 0,2 mg tabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
562 |
Desmotabs® 0,2mg tabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
563 |
Determination of drug effects through amantadine cessation |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
564 |
Device: abdominal compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
565 |
Device: actimyo recording |
- |
- |
- |
- |
006 [1] 6 💬 |
566 |
Device: active tdcs |
- |
- |
- |
- |
006 [1] 6 💬 |
567 |
Device: active tpcs |
- |
- |
- |
- |
006 [1] 6 💬 |
568 |
Device: adaptor: hakko adaptor |
- |
- |
- |
- |
006 [1] 6 💬 |
569 |
Device: aha exergame system |
- |
- |
- |
- |
006 [1] 6 💬 |
570 |
Device: b-stn dbs |
- |
- |
- |
- |
006 [1] 6 💬 |
571 |
Device: balance training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
572 |
Device: balance training with nintendo wii fit |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
573 |
Device: cadd-legacy ambulatory infusion pump |
- |
- |
- |
- |
006 [1] 6 💬 |
574 |
Device: cadd-legacy® 1400 ambulatory infusion pump |
- |
- |
- |
- |
006 [1] 6 💬 |
575 |
Device: carbon fiber ankle foot orthosis (afo) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
576 |
Device: clonidine (catapressan) |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
577 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
578 |
Device: functional magnetic resonance imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
579 |
Device: infusion pump: cadd-legacy® 1400 pump |
- |
- |
- |
- |
006 [1] 6 💬 |
580 |
Device: inspiratory muscle training |
- |
- |
- |
- |
006 [1] 6 💬 |
581 |
Device: j-tube |
- |
- |
- |
- |
006 [1] 6 💬 |
582 |
Device: jejunal extension tube |
- |
- |
- |
- |
006 [1] 6 💬 |
583 |
Device: jejunal extension tube (j-tube) |
- |
- |
- |
- |
006 [1] 6 💬 |
584 |
Device: kinetra and soletra (neurostimulator, medtronic) |
- |
- |
- |
- |
006 [1] 6 💬 |
585 |
Device: light box ( litebook company) |
- |
- |
- |
- |
006 [1] 6 💬 |
586 |
Device: light box (litebook company) |
- |
- |
- |
- |
006 [1] 6 💬 |
587 |
Device: magnetic resonance imaging |
- |
- |
- |
- |
006 [5] 6 , 13, 22, 34, 299 💬 |
588 |
Device: massage with a spiky ball |
- |
- |
- |
- |
006 [1] 6 💬 |
589 |
Device: ms band 2 |
- |
- |
- |
- |
006 [1] 6 💬 |
590 |
Device: nebulizer |
- |
- |
- |
- |
006 [1] 6 💬 |
591 |
Device: nj-tube: silicon ed tube |
Silicon |
- |
- |
- |
006 [1] 6 💬 |
592 |
Device: oct - tce |
- |
- |
- |
- |
006 [1] 6 💬 |
593 |
Device: peg tube |
- |
- |
- |
- |
006 [1] 6 💬 |
594 |
Device: percutaneous endoscopic gastrostomy tube |
- |
- |
- |
- |
006 [1] 6 💬 |
595 |
Device: percutaneous endoscopic gastrostomy tube (peg tube) |
- |
- |
- |
- |
006 [1] 6 💬 |
596 |
Device: renishaw drug delivery system |
- |
- |
- |
- |
006 [1] 6 💬 |
597 |
Device: resistive respiratory loads |
- |
- |
- |
- |
006 [1] 6 💬 |
598 |
Device: sham compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
599 |
Device: sham tdcs |
- |
- |
- |
- |
006 [1] 6 💬 |
600 |
Device: sham tpcs |
- |
- |
- |
- |
006 [1] 6 💬 |
601 |
Device: spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
602 |
Device: spoton balance glasses |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
603 |
Device: stimulator off |
- |
- |
- |
- |
006 [1] 6 💬 |
604 |
Device: stimulator on |
- |
- |
- |
- |
006 [1] 6 💬 |
605 |
Dexdor |
- |
- |
- |
- |
002 [4] 2 , 4 , 6 , 70 💬 |
606 |
Dexmedetomidina |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
607 |
Dexmedetomidine |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
608 |
Dexmedetomidine hydrochloride infusion |
Dexmedetomidine |
[2] D00514 D00514, D01205 D01205 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
609 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
610 |
Dha |
- |
- |
- |
- |
006 [8] 6 , 46, 48, 49, 94, 113, 299, 301 💬 |
611 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
612 |
Diagnostic test: auto-assessment manikins (sam) |
- |
- |
- |
- |
006 [1] 6 💬 |
613 |
Diagnostic test: barcelona test (bt) |
- |
- |
- |
- |
006 [1] 6 💬 |
614 |
Diagnostic test: beam test to predict falls |
Tricyclazole |
- |
- |
- |
006 [1] 6 💬 |
615 |
Diagnostic test: beck depression inventory-ii (bdi-ii) |
- |
- |
- |
- |
006 [1] 6 💬 |
616 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
617 |
Diagnostic test: flutemetamol f18 injection |
Flutemetamol |
[1] D10231 D10231 💬 |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
618 |
Diagnostic test: frontal assessment battery (fab) |
- |
- |
- |
- |
006 [1] 6 💬 |
619 |
Diagnostic test: global deterioration scale (gds) |
- |
- |
- |
- |
006 [1] 6 💬 |
620 |
Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
621 |
Diagnostic test: measurement of serum level of anti-dementia drug |
- |
- |
- |
- |
006 [1] 6 💬 |
622 |
Diagnostic test: memory alteration test (m@t) |
- |
- |
- |
- |
006 [1] 6 💬 |
623 |
Diagnostic test: mini cognitive examination (mce) |
- |
- |
- |
- |
006 [1] 6 💬 |
624 |
Diagnostic test: neuropsychological assessment |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
625 |
Diagnostic test: positive and negative affect scale (panas) |
- |
- |
- |
- |
006 [1] 6 💬 |
626 |
Diagnostic test: respiratory muscle strength |
- |
- |
- |
- |
006 [1] 6 💬 |
627 |
Diagnostic test: rey-osterrieth complex figure test (rocft) |
- |
- |
- |
- |
006 [1] 6 💬 |
628 |
Diagnostic test: spanish-complutense verbal learning test (tavec) |
- |
- |
- |
- |
006 [1] 6 💬 |
629 |
Diagnostic test: supplementary neuropsychological assessment - parkinson's disease |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
630 |
Different diets |
- |
- |
- |
- |
006 [1] 6 💬 |
631 |
Dihydroergotoxine mesylate |
Ergoloid mesylate |
[1] D02268 D02268 💬 |
ADRA1A [6] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
632 |
Dipivefrin |
Dipivefrin |
[1] D02349 D02349 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
633 |
Dipivefrine |
Dipivefrin |
[1] D02349 D02349 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
634 |
Dipraglurant |
Dipraglurant |
- |
- |
- |
006 [1] 6 💬 |
635 |
Ditropan elixir |
- |
- |
- |
- |
006 [1] 6 💬 |
636 |
Dm |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
637 |
Dm-1992 |
- |
- |
- |
- |
006 [1] 6 💬 |
638 |
Dmi |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
639 |
Dnl151 |
- |
- |
- |
- |
006 [1] 6 💬 |
640 |
Dnl201 |
- |
- |
- |
- |
006 [1] 6 💬 |
641 |
Dns-7801 (high dose) |
- |
- |
- |
- |
006 [1] 6 💬 |
642 |
Dns-7801 (low-dose) |
- |
- |
- |
- |
006 [1] 6 💬 |
643 |
Docosahexaenoic acid |
Doconexent |
- |
- |
- |
006 [7] 6 , 49, 90, 94, 240, 299, 301 💬 |
644 |
Docosahexaenoic acid (dha) |
Doconexent |
- |
- |
- |
006 [3] 6 , 94, 299 💬 |
645 |
Domperidone |
Domperidone |
[2] D01745 D01745, D07868 D07868 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [5] 6 , 13, 17, 51, 230 💬 |
646 |
Domperidone (drug) |
Domperidone |
[2] D01745 D01745, D07868 D07868 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
647 |
Dompéridone |
- |
- |
- |
- |
006 [1] 6 💬 |
648 |
Donepezil |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [9] 5 , 6 , 13, 46, 78, 124, 127, 156, 206 💬 |
649 |
Donepezil hydrochloride |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [3] 6 , 124, 156 💬 |
650 |
Donepezil sandoz |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
651 |
Dopamine |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 7 , 74 💬 |
652 |
Dopamine agent |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
653 |
Dopamine agonists (pramipexole, ropirinole) |
Dopamine |
[4] D00559 D00559, D00633 D00633, D05575 D05575, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
654 |
Dopaminergic agonist + apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
655 |
Dopaminergic agonists |
- |
- |
- |
- |
006 [1] 6 💬 |
656 |
Dops |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [2] 6 , 17 💬 |
657 |
Doxepin |
Doxepin |
[2] D00814 D00814, D07875 D07875 💬 |
HRH1 [3] HRH1, SLC6A2, SLC6A4 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
658 |
Doxepin and zopiclone |
Doxepin |
[3] D00814 D00814, D01372 D01372, D07875 D07875 💬 |
GABRA1 [19] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 |
Calcium signaling pathway [10] Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction |
006 [1] 6 💬 |
659 |
Dpa |
- |
- |
- |
- |
002 [4] 2 , 6 , 13, 85 💬 |
660 |
Dpa-714-pet/mri |
- |
- |
- |
- |
006 [1] 6 💬 |
661 |
Droxidopa |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 [3] 5 , 6 , 17 💬 |
662 |
Droxidopa 100 mg [northera] |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
663 |
Duloxetine |
Duloxetine |
[2] D01179 D01179, D07880 D07880 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 13 💬 |
664 |
Duloxetine hydrochloride |
Duloxetine |
[2] D01179 D01179, D07880 D07880 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
665 |
Duodopa |
- |
- |
- |
- |
006 [1] 6 💬 |
666 |
Duodopa gel intestinale |
- |
- |
- |
- |
006 [1] 6 💬 |
667 |
Duodopa intestinal gel |
- |
- |
- |
- |
006 [1] 6 💬 |
668 |
Duodopa intestinalgel |
- |
- |
- |
- |
006 [1] 6 💬 |
669 |
Duodopa ld/cd 20/5 mg/ml |
- |
- |
- |
- |
006 [1] 6 💬 |
670 |
Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel |
- |
- |
- |
- |
006 [1] 6 💬 |
671 |
Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
672 |
Duodopa®intestinal gel |
- |
- |
- |
- |
006 [1] 6 💬 |
673 |
Dynacirc cr (isradipine) |
Isradipine |
[1] D00349 D00349 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
674 |
E2007 |
- |
- |
- |
- |
006 [2] 6 , 144 💬 |
675 |
Ebixa |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
676 |
Ebixa® |
- |
- |
- |
- |
006 [1] 6 💬 |
677 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
678 |
Elc200 |
- |
- |
- |
- |
006 [1] 6 💬 |
679 |
Eliprodil |
Eliprodil |
- |
- |
- |
006 [1] 6 💬 |
680 |
Elobixibat |
Elobixibat |
[1] D10796 D10796 💬 |
SLC10A2 [1] SLC10A2 💬 |
Bile secretion [1] Bile secretion |
006 [1] 6 💬 |
681 |
Eltoprazine |
Eltoprazine |
- |
- |
- |
006 [1] 6 💬 |
682 |
Eltoprazine hcl |
Eltoprazine |
- |
- |
- |
006 [1] 6 💬 |
683 |
Eltoprazine hydrochloride |
Eltoprazine |
- |
- |
- |
006 [1] 6 💬 |
684 |
Emd 128130 |
- |
- |
- |
- |
006 [2] 6 , 156 💬 |
685 |
Emd128130 |
- |
- |
- |
- |
006 [1] 6 💬 |
686 |
En |
- |
- |
- |
- |
006 [3] 6 , 46, 97 💬 |
687 |
Ena713 |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
688 |
Ena713b |
- |
- |
- |
- |
006 [1] 6 💬 |
689 |
Ent-01 |
- |
- |
- |
- |
006 [1] 6 💬 |
690 |
Entacapon |
- |
- |
- |
- |
006 [1] 6 💬 |
691 |
Entacapona |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
692 |
Entacapone |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
693 |
Entacapone 400mg oral dose |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
694 |
Entacapone and carbidopa |
Carbidopa |
[2] D00558 D00558, D00781 D00781 💬 |
COMT [2] COMT, DDC 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
695 |
Entacapone inn |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
696 |
Entecapone |
- |
- |
- |
- |
006 [1] 6 💬 |
697 |
Epi-589 |
EPI-589 |
- |
- |
- |
002 [2] 2 , 6 💬 |
698 |
Epi-743 200mg |
- |
- |
- |
- |
006 [1] 6 💬 |
699 |
Epi-743 400mg |
- |
- |
- |
- |
006 [1] 6 💬 |
700 |
Equal |
- |
- |
- |
- |
006 [5] 6 , 13, 67, 86, 230 💬 |
701 |
Er cd-ld |
- |
- |
- |
- |
006 [1] 6 💬 |
702 |
Er tablet 100 mg azd3241 |
- |
- |
- |
- |
006 [1] 6 💬 |
703 |
Er tablet 25 mg azd3241 |
- |
- |
- |
- |
006 [1] 6 💬 |
704 |
Eradication of helcobacter pylori |
- |
- |
- |
- |
006 [1] 6 💬 |
705 |
Eradication therapy for h.pylori infection |
- |
- |
- |
- |
006 [1] 6 💬 |
706 |
Eradication therapy for helicobacter pylori |
- |
- |
- |
- |
006 [1] 6 💬 |
707 |
Erythromycin |
Erythromycin |
[9] D00140 D00140, D00851 D00851, D01361 D01361, D02009 D02009, D02184 D02184, D02523 D02523, D02524 D02524, D02525 D02525, D04054 D04054 💬 |
- |
- |
006 [5] 6 , 36, 164, 228, 291 💬 |
708 |
Erythropoietin |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [9] 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
709 |
Erythropoietin human recombinant (eporh) |
Erythropoietin |
[1] D03231 D03231 💬 |
EPOR [1] EPOR 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
006 [1] 6 💬 |
710 |
Escitalopram |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
002 [3] 2 , 6 , 13 💬 |
711 |
Escitalopram oxalate |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
712 |
Eszopiclone |
Eszopiclone |
[1] D02624 D02624 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [3] 6 , 13, 46 💬 |
713 |
Ethnodyne visio |
- |
- |
- |
- |
006 [1] 6 💬 |
714 |
Ethylmethylcarbamic acid 3-[(1s)-1-(dimethylamino)ethyl]phenyl ester (**see other 2 names below) |
- |
- |
- |
- |
006 [1] 6 💬 |
715 |
Exametazime |
Exametazime |
[1] D01109 D01109 💬 |
- |
- |
006 [1] 6 💬 |
716 |
Exelon |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
717 |
Exelon 4.6 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
718 |
Exelon 9.5 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
719 |
Exelon patch |
- |
- |
- |
- |
006 [1] 6 💬 |
720 |
Exelon patch (rivastigmine transdermal system) |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
721 |
Exelon path transdermal |
- |
- |
- |
- |
006 [1] 6 💬 |
722 |
Exelon ® |
- |
- |
- |
- |
006 [1] 6 💬 |
723 |
Exenatide |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [4] 6 , 17, 193, 233 💬 |
724 |
Exenatide 10 micrograms |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [1] 6 💬 |
725 |
Exenatide 5 micrograms |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [1] 6 💬 |
726 |
Exenatide extended release 2mg (bydureon) |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [1] 6 💬 |
727 |
F-18 fpcit |
- |
- |
- |
- |
006 [1] 6 💬 |
728 |
Famotidine |
Famotidine |
[1] D00318 D00318 💬 |
HRH2 [1] HRH2 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 [4] 6 , 46, 86, 98 💬 |
729 |
Fb-101 |
- |
- |
- |
- |
006 [1] 6 💬 |
730 |
Febuxostat |
Febuxostat |
[1] D01206 D01206 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
002 [3] 2 , 6 , 13 💬 |
731 |
Ferriprox |
- |
- |
- |
- |
006 [2] 6 , 120 💬 |
732 |
Ferriprox 500 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
733 |
Ferrprox (deferiprone) |
Deferiprone |
[1] D07416 D07416 💬 |
- |
- |
006 [1] 6 💬 |
734 |
Fesoterodine |
Fesoterodine |
[1] D07226 D07226 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
735 |
Fetal porcine cells, neurocell-pd |
- |
- |
- |
- |
006 [1] 6 💬 |
736 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
737 |
Finamine tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
738 |
Finasteride |
Finasteride |
[1] D00321 D00321 💬 |
SRD5A2 [1] SRD5A2 💬 |
Prostate cancer [2] Prostate cancer, Steroid hormone biosynthesis |
006 [1] 6 💬 |
739 |
Fipamezole |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
740 |
Fipamezole hydrochloride |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
741 |
Fipamezole hydrochloride 30 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
742 |
Fipamezole hydrochloride 60 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
743 |
Fipamezole hydrochloride 90 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
744 |
Fipamezole odt |
Fipamezole |
- |
- |
- |
006 [1] 6 💬 |
745 |
Fipamezole odt cohort 2 |
Fipamezole |
- |
- |
- |
006 [1] 6 💬 |
746 |
Flecainide |
Flecainide |
[2] D00638 D00638, D07962 D07962 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
747 |
Flecainide acetate |
Acetate |
[2] D00638 D00638, D07962 D07962 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
748 |
Flecainidum |
Flecainide |
[2] D00638 D00638, D07962 D07962 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
749 |
Florbetaben (18f) |
- |
- |
- |
- |
006 [1] 6 💬 |
750 |
Florbetapir f 18 |
- |
- |
- |
- |
006 [1] 6 💬 |
751 |
Fludrocortisone |
Fludrocortisone |
[2] D00986 D00986, D07967 D07967 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
006 [3] 6 , 17, 81 💬 |
752 |
Flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [5] 6 , 13, 17, 18, 206 💬 |
753 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
754 |
Flutemetamol f18 |
Flutemetamol |
[1] D10231 D10231 💬 |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
755 |
Folic acid |
Folic acid |
[1] D00070 D00070 💬 |
- |
- |
006 [4] 6 , 46, 49, 84 💬 |
756 |
Folic acid, vitamin b6, vitamin b12 |
Cyanocobalamin |
[7] D00070 D00070, D00166 D00166, D02179 D02179, D03615 D03615, D03616 D03616, D03617 D03617, D08454 D08454 💬 |
- |
- |
006 [1] 6 💬 |
757 |
Foliglurax |
Foliglurax |
- |
- |
- |
006 [1] 6 💬 |
758 |
Foliglurax 10 mg (treatment a) |
Foliglurax |
- |
- |
- |
006 [1] 6 💬 |
759 |
Foliglurax 30 mg (treatment b) |
Foliglurax |
- |
- |
- |
006 [1] 6 💬 |
760 |
Foscarbidopa |
Foscarbidopa |
- |
- |
- |
006 [1] 6 💬 |
761 |
Foscarbidopa and foslevodopa |
Foscarbidopa |
- |
- |
- |
006 [1] 6 💬 |
762 |
Foslevodopa |
- |
- |
- |
- |
006 [1] 6 💬 |
763 |
Fpf1100nw |
- |
- |
- |
- |
006 [1] 6 💬 |
764 |
Fpfs-1169 |
- |
- |
- |
- |
006 [1] 6 💬 |
765 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
766 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
767 |
Gabapentina |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [1] 6 💬 |
768 |
Gabapentina kern pharma |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [1] 6 💬 |
769 |
Galantamine |
Galantamine |
[2] D02173 D02173, D04292 D04292 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [2] 6 , 127 💬 |
770 |
Ganoderma |
- |
- |
- |
- |
006 [1] 6 💬 |
771 |
Genetic: optional pharmacogenetic assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
772 |
Genz-682452 |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
773 |
Genz-682452-au |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
774 |
Ghrelin |
Lenomorelin |
- |
- |
- |
006 [3] 6 , 78, 299 💬 |
775 |
Ginkgo |
Ginkgo biloba |
- |
- |
- |
006 [4] 6 , 13, 18, 90 💬 |
776 |
Glial cell line-derived neurotrophic factor |
- |
- |
- |
- |
006 [1] 6 💬 |
777 |
Glial cell line-derived neurotrophic factor (gdnf) |
- |
- |
- |
- |
006 [1] 6 💬 |
778 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 [15] 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
779 |
Glutathione |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
006 [2] 6 , 299 💬 |
780 |
Glycerol |
Glycerin |
[1] D00028 D00028 💬 |
- |
- |
006 [5] 6 , 13, 79, 316, 317 💬 |
781 |
Glycerol phenylbutyrate |
Glycerin |
[3] D00028 D00028, D05868 D05868, D10127 D10127 💬 |
- |
- |
006 [1] 6 💬 |
782 |
Glycopyrrolate |
- |
- |
- |
- |
006 [2] 6 , 34 💬 |
783 |
Gm1 ganglioside |
- |
- |
- |
- |
006 [1] 6 💬 |
784 |
Gm608 |
- |
- |
- |
- |
006 [1] 6 💬 |
785 |
Gocovri |
- |
- |
- |
- |
006 [1] 6 💬 |
786 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
787 |
Gold nanocrystals |
Gold |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
788 |
Gpi 1485 |
- |
- |
- |
- |
006 [1] 6 💬 |
789 |
Grapefruit |
Grapefruit |
- |
- |
- |
006 [5] 6 , 46, 50, 83, 97 💬 |
790 |
Green tea |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
006 [5] 6 , 17, 28, 46, 96 💬 |
791 |
Green tea polyphenols (egcg/ecg) |
Epigallocatechin gallate |
[1] D06903 D06903 💬 |
- |
- |
006 [1] 6 💬 |
792 |
Grf6021 |
- |
- |
- |
- |
006 [1] 6 💬 |
793 |
Group ad anti-pd + antidepressant |
- |
- |
- |
- |
006 [1] 6 💬 |
794 |
Group r rasagiline |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
795 |
Group r+ad rasagiline + antidepressant |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
796 |
Gsh |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
797 |
Gsk962040 |
- |
- |
- |
- |
006 [1] 6 💬 |
798 |
Gsk962040 (25 mg tablet) |
- |
- |
- |
- |
006 [1] 6 💬 |
799 |
Guar gum |
Guar gum |
[1] D04403 D04403 💬 |
- |
- |
006 [1] 6 💬 |
800 |
Gz/sar402671 |
- |
- |
- |
- |
006 [2] 6 , 19 💬 |
801 |
Hb-admscs |
Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins |
- |
- |
- |
002 [3] 2 , 6 , 46 💬 |
802 |
Hec122505msoh |
- |
- |
- |
- |
006 [1] 6 💬 |
803 |
Helicobacter pylori eradication therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
804 |
Heptaminol |
Heptaminol |
[1] D07158 D07158 💬 |
- |
- |
006 [1] 6 💬 |
805 |
Heptaminol hydrochloride |
Heptaminol |
[1] D07158 D07158 💬 |
- |
- |
006 [1] 6 💬 |
806 |
Herbal medicinal mixture (roucongrong, heshouwu etc.) |
Reynoutria multiflora root |
- |
- |
- |
006 [1] 6 💬 |
807 |
Hericium erinaceus mycelium |
- |
- |
- |
- |
006 [1] 6 💬 |
808 |
Heshouwu |
Reynoutria multiflora root |
- |
- |
- |
006 [1] 6 💬 |
809 |
Hf0220 |
- |
- |
- |
- |
006 [1] 6 💬 |
810 |
High dose affitope® pd03a + adjuvant |
- |
- |
- |
- |
006 [1] 6 💬 |
811 |
High dose anavex2-73 |
- |
- |
- |
- |
006 [1] 6 💬 |
812 |
High protein. t-diet plus range |
- |
- |
- |
- |
006 [1] 6 💬 |
813 |
Hp-3000 (ropinirole hydrochloride patch) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
814 |
Hp-3000 placebo |
- |
- |
- |
- |
006 [1] 6 💬 |
815 |
Hp-3000(ropinirole hydrochloride patch) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
816 |
Human amniotic epithelial stem cells |
- |
- |
- |
- |
006 [1] 6 💬 |
817 |
Human neural stem cell |
- |
- |
- |
- |
006 [1] 6 💬 |
818 |
Human stem cells |
- |
- |
- |
- |
006 [1] 6 💬 |
819 |
Hydrocortisone |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [9] 6 , 46, 53, 75, 78, 81, 83, 97, 299 💬 |
820 |
Hydrocortisone cream |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
821 |
Hydrocortisone cream 1% |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
822 |
Hydrocortisone cream 10mg/g fna fagron |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
823 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 [7] 5 , 6 , 13, 17, 83, 97, 226 💬 |
824 |
Hydrolyzed guar gum |
Guar gum |
[1] D04403 D04403 💬 |
- |
- |
006 [1] 6 💬 |
825 |
I 123 |
Iodide I-123 |
- |
- |
- |
006 [1] 6 💬 |
826 |
I-123 |
Iodide I-123 |
- |
- |
- |
002 [2] 2 , 6 💬 |
827 |
I-123-5-ia85380 |
Iodide I-123 |
- |
- |
- |
006 [1] 6 💬 |
828 |
I123 |
- |
- |
- |
- |
006 [1] 6 💬 |
829 |
Iberogast |
- |
- |
- |
- |
006 [1] 6 💬 |
830 |
Idebenone |
Idebenone |
[1] D01750 D01750 💬 |
- |
- |
006 [5] 6 , 13, 18, 113, 302 💬 |
831 |
Immediate release carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
832 |
Immediate release carbidopa/levodopa 10/100 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
833 |
Immediate release carbidopa/levodopa 25/100 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
834 |
Impact |
- |
- |
- |
- |
006 [8] 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
835 |
Incobotulinum toxin a |
- |
- |
- |
- |
002 [3] 2 , 6 , 13 💬 |
836 |
Incobotulinumtoxina |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [1] 6 💬 |
837 |
Incobotulinumtoxina (100 units) |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [1] 6 💬 |
838 |
Incobotulinumtoxina (75 units) |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [1] 6 💬 |
839 |
Infudopa i.v. |
- |
- |
- |
- |
006 [1] 6 💬 |
840 |
Infudopa s.c. |
- |
- |
- |
- |
006 [1] 6 💬 |
841 |
Infusions of young plasma |
- |
- |
- |
- |
006 [1] 6 💬 |
842 |
Inhaled vr040 |
- |
- |
- |
- |
006 [1] 6 💬 |
843 |
Injection of apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
844 |
Injection of normal saline |
- |
- |
- |
- |
006 [1] 6 💬 |
845 |
Injection of umbilical cord derived mscs |
- |
- |
- |
- |
006 [1] 6 💬 |
846 |
Inosine |
Inosine |
[1] D00054 D00054 💬 |
- |
- |
002 [4] 2 , 6 , 13, 17 💬 |
847 |
Intracerebral microinjections |
- |
- |
- |
- |
006 [1] 6 💬 |
848 |
Intranasal glutathione - (in)gsh |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
006 [1] 6 💬 |
849 |
Intranasal insulin |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
850 |
Intravenous and oral n-acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [1] 6 💬 |
851 |
Intravenous infusion |
- |
- |
- |
- |
006 [1] 6 💬 |
852 |
Intravenous levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
853 |
Intravesical injection of botulinum a toxin |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
854 |
Ioflupane (123i) |
- |
- |
- |
- |
006 [1] 6 💬 |
855 |
Ioflupane 123i (datscan®) |
- |
- |
- |
- |
006 [1] 6 💬 |
856 |
Ioflupane [123 i] |
- |
- |
- |
- |
006 [1] 6 💬 |
857 |
Ioflupane [123i] |
- |
- |
- |
- |
006 [1] 6 💬 |
858 |
Ioflupane i 123 |
Iodide I-123 |
[1] D10014 D10014 💬 |
- |
- |
006 [1] 6 💬 |
859 |
Ipratropium |
Ipratropium |
[1] D02212 D02212 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
860 |
Ipratropium bromide (drug) |
Ipratropium |
[1] D02212 D02212 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
861 |
Iproniazid |
Iproniazid |
[1] D02579 D02579 💬 |
MAOA [2] MAOA, MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
862 |
Ips-nsc cells |
- |
- |
- |
- |
006 [1] 6 💬 |
863 |
Ipt803 |
- |
- |
- |
- |
006 [1] 6 💬 |
864 |
Ipx054 100 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
865 |
Ipx054 150 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
866 |
Ipx054 200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
867 |
Ipx054 250 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
868 |
Ipx054 300 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
869 |
Ipx066 |
- |
- |
- |
- |
006 [1] 6 💬 |
870 |
Ipx066 145 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
871 |
Ipx066 145 mg ld |
- |
- |
- |
- |
006 [1] 6 💬 |
872 |
Ipx066 195 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
873 |
Ipx066 195 mg ld |
- |
- |
- |
- |
006 [1] 6 💬 |
874 |
Ipx066 245 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
875 |
Ipx066 245 mg ld |
- |
- |
- |
- |
006 [1] 6 💬 |
876 |
Ipx066 95 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
877 |
Ipx066 95 mg ld |
- |
- |
- |
- |
006 [1] 6 💬 |
878 |
Ipx066-145 |
- |
- |
- |
- |
006 [1] 6 💬 |
879 |
Ipx066-195 |
- |
- |
- |
- |
006 [1] 6 💬 |
880 |
Ipx066-245 |
- |
- |
- |
- |
006 [1] 6 💬 |
881 |
Ipx066-95 |
- |
- |
- |
- |
006 [1] 6 💬 |
882 |
Ipx203 |
- |
- |
- |
- |
006 [1] 6 💬 |
883 |
Ipx203 140 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
884 |
Ipx203 180 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
885 |
Ipx203 210 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
886 |
Ipx203 270 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
887 |
Ipx203 280 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
888 |
Ipx203 350 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
889 |
Ipx203 er cd-ld |
- |
- |
- |
- |
006 [1] 6 💬 |
890 |
Ir cd-ld |
- |
- |
- |
- |
006 [1] 6 💬 |
891 |
Ir cd-ld (carbidopa-levodopa) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
892 |
Ir ld / cd |
- |
- |
- |
- |
006 [1] 6 💬 |
893 |
Ir ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
894 |
Irl752 |
- |
- |
- |
- |
006 [1] 6 💬 |
895 |
Irl790 |
- |
- |
- |
- |
006 [1] 6 💬 |
896 |
Irx4204 |
- |
- |
- |
- |
006 [1] 6 💬 |
897 |
Isc-hpnsc |
- |
- |
- |
- |
006 [1] 6 💬 |
898 |
Isicom |
- |
- |
- |
- |
006 [1] 6 💬 |
899 |
Isoflurane |
Isoflurane |
[1] D00545 D00545 💬 |
- |
- |
006 [1] 6 💬 |
900 |
Isradipine |
Isradipine |
[1] D00349 D00349 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
901 |
Isradipine cr 10mg |
Isradipine |
[1] D00349 D00349 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
902 |
Isradipine cr 20mg |
Isradipine |
[1] D00349 D00349 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
903 |
Isradipine cr 5mg |
Isradipine |
[1] D00349 D00349 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
904 |
Istradefylline |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
905 |
Istradefylline ( kw-6002) |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
906 |
Istradefylline (kw-6002) |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
907 |
Istradefylline 20 mg |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
908 |
Istradefylline 20 mg or 40 mg |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
909 |
Istradefylline 40 mg |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
910 |
Iti-214 |
ITI-214 |
- |
- |
- |
006 [1] 6 💬 |
911 |
Iv apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
912 |
Iv levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
913 |
Izd174 |
- |
- |
- |
- |
006 [2] 6 , 106 💬 |
914 |
Jm |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
915 |
Jm-010 |
- |
- |
- |
- |
006 [1] 6 💬 |
916 |
Jm-010 group a |
- |
- |
- |
- |
006 [1] 6 💬 |
917 |
Jm-010 group b |
- |
- |
- |
- |
006 [1] 6 💬 |
918 |
Jnj-31001074 |
- |
- |
- |
- |
006 [1] 6 💬 |
919 |
Jnj31-31001074 |
- |
- |
- |
- |
006 [1] 6 💬 |
920 |
Jp 1730 |
- |
- |
- |
- |
006 [1] 6 💬 |
921 |
Jp-1730/f01 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
922 |
Jp-1730/f02 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
923 |
Jp-1730/f03 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
924 |
Jzp-110 |
- |
- |
- |
- |
006 [1] 6 💬 |
925 |
K0706 |
- |
- |
- |
- |
006 [1] 6 💬 |
926 |
Kdt-3594 |
- |
- |
- |
- |
006 [1] 6 💬 |
927 |
Ketone ester drink |
- |
- |
- |
- |
006 [1] 6 💬 |
928 |
Ketone ester elite endurance nutrition drink |
- |
- |
- |
- |
006 [1] 6 💬 |
929 |
Kinoquinone (proposed) |
- |
- |
- |
- |
006 [1] 6 💬 |
930 |
Km-819 |
- |
- |
- |
- |
006 [1] 6 💬 |
931 |
Kw-6002 |
- |
- |
- |
- |
006 [1] 6 💬 |
932 |
Kw-6002 (istradefylline) |
Istradefylline |
[1] D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
933 |
Kw-6356 |
- |
- |
- |
- |
006 [1] 6 💬 |
934 |
Kw-6356 high dose |
- |
- |
- |
- |
006 [1] 6 💬 |
935 |
Kw-6356 low dose |
- |
- |
- |
- |
006 [1] 6 💬 |
936 |
Kw-6356 middle dose |
- |
- |
- |
- |
006 [1] 6 💬 |
937 |
Kw-6356 x dose |
- |
- |
- |
- |
006 [1] 6 💬 |
938 |
Kw-6356 y dose |
- |
- |
- |
- |
006 [1] 6 💬 |
939 |
Kw-6500 |
- |
- |
- |
- |
006 [1] 6 💬 |
940 |
L-123 ioflupane |
- |
- |
- |
- |
006 [1] 6 💬 |
941 |
L-3-(3,4-dihydroxyphenyl)alanine |
Alanine |
[1] D00012 D00012 💬 |
- |
- |
006 [1] 6 💬 |
942 |
L-dopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
943 |
L-dopa/ modopar |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
944 |
L-dops |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
945 |
L-methylfolate |
Levomefolic acid |
[1] D09353 D09353 💬 |
- |
- |
006 [1] 6 💬 |
946 |
L-tyrosine |
Tyrosine |
[1] D00022 D00022 💬 |
- |
- |
006 [2] 6 , 111 💬 |
947 |
La |
- |
- |
- |
- |
006 [5] 6 , 13, 75, 76, 222 💬 |
948 |
Lactobacillus casei dg (enterolactis duo®) |
- |
- |
- |
- |
006 [1] 6 💬 |
949 |
Lactobacillus plantarum |
Lactobacillus plantarum |
- |
- |
- |
006 [3] 6 , 97, 156 💬 |
950 |
Lactobacillus plantarum ps128 |
Lactobacillus plantarum |
- |
- |
- |
006 [1] 6 💬 |
951 |
Lactose |
Lactose |
[2] D00046 D00046, D03226 D03226 💬 |
- |
- |
002 [6] 2 , 6 , 13, 97, 228, 310 💬 |
952 |
Lcig |
- |
- |
- |
- |
006 [1] 6 💬 |
953 |
Lcig (duodopa) |
- |
- |
- |
- |
006 [1] 6 💬 |
954 |
Ld / be |
- |
- |
- |
- |
006 [1] 6 💬 |
955 |
Ld+ddci |
- |
- |
- |
- |
006 [1] 6 💬 |
956 |
Ld-ddci |
- |
- |
- |
- |
006 [1] 6 💬 |
957 |
Ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
958 |
Leptin |
Leptin |
- |
- |
- |
006 [2] 6 , 265 💬 |
959 |
Leucine |
Leucine |
[1] D00030 D00030 💬 |
- |
- |
005 [10] 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
960 |
Levetiracetam |
Levetiracetam |
[1] D00709 D00709 💬 |
SV2A [1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
002 [4] 2 , 4 , 6 , 13 💬 |
961 |
Levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
962 |
Levodopa (dc.it) (fu) |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
963 |
Levodopa (delivered intravenously) |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
964 |
Levodopa (drug), intraduodenal administration |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
965 |
Levodopa (l-dopa) |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
966 |
Levodopa (l-dopa) + standard care |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
967 |
Levodopa / benserazid |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
968 |
Levodopa / benserazide 200 + 50 mg |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
969 |
Levodopa 100 mg / benserazide 25 mg |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
970 |
Levodopa 100 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
971 |
Levodopa 125 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
972 |
Levodopa 150 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
973 |
Levodopa 25mg/100mg |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
974 |
Levodopa 75 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
975 |
Levodopa acute challenge |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
976 |
Levodopa and carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
977 |
Levodopa and carbidopa sc solution |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
978 |
Levodopa and carbidopa solution for sc administration |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
979 |
Levodopa and decarboxylase inhibitor |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
980 |
Levodopa and domperidone |
Domperidone |
[3] D00059 D00059, D01745 D01745, D07868 D07868 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
981 |
Levodopa benserazide madopar |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
982 |
Levodopa benserazide teva italia |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
983 |
Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
984 |
Levodopa carbidopa intestinal gel (lcig) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
985 |
Levodopa cr (controlled release) |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
986 |
Levodopa cyclops |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
987 |
Levodopa dc.it fu |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
988 |
Levodopa dispersible |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
989 |
Levodopa infusion |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
990 |
Levodopa inn |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
991 |
Levodopa mr |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
992 |
Levodopa powder for inhalation |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
993 |
Levodopa tablet |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
994 |
Levodopa, carbidopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
995 |
Levodopa, carbidopa, odm-104 |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
996 |
Levodopa, decarboxylase inhibitor and comt inhibitor |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
997 |
Levodopa-4'-monophosphate |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
998 |
Levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [2] 6 , 90 💬 |
999 |
Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1000 |
Levodopa-carbidopa immediate release (lc-ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1001 |
Levodopa-carbidopa intestinal gel |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1002 |
Levodopa-carbidopa intestinal gel (lcig) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1003 |
Levodopa-carbidopa multilayer extended release tablet |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1004 |
Levodopa-carbidopa xl tablet (m) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1005 |
Levodopa-carbidopa-entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1006 |
Levodopa/benserazide |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1007 |
Levodopa/benserazide 100/25 mg |
Benserazide |
[2] D00059 D00059, D03082 D03082 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1008 |
Levodopa/benzeraside |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1009 |
Levodopa/benzerazide |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1010 |
Levodopa/carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [2] 6 , 164 💬 |
1011 |
Levodopa/carbidopa (ld/cd) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1012 |
Levodopa/carbidopa (sinemet) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1013 |
Levodopa/carbidopa 100/25 |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1014 |
Levodopa/carbidopa hydrate |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1015 |
Levodopa/carbidopa solution |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1016 |
Levodopa/carbidopa(200mg/50mg) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1017 |
Levodopa/carbidopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1018 |
Levodopa/ddci |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1019 |
Levodopa/dopa decarboxylase inhibitor |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1020 |
Liatermin |
Liatermin |
[1] D04727 D04727 💬 |
- |
- |
006 [1] 6 💬 |
1021 |
Liatermin (r-methugdnf) |
Liatermin |
[1] D04727 D04727 💬 |
- |
- |
006 [1] 6 💬 |
1022 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
1023 |
Lingzhi (ganoderma) |
- |
- |
- |
- |
006 [1] 6 💬 |
1024 |
Lipuro |
- |
- |
- |
- |
006 [1] 6 💬 |
1025 |
Liquigen mct oil |
- |
- |
- |
- |
006 [1] 6 💬 |
1026 |
Liraglutide |
Liraglutide |
[1] D06404 D06404 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [3] 6 , 75, 193 💬 |
1027 |
Lisparin |
- |
- |
- |
- |
006 [1] 6 💬 |
1028 |
Lisuride |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 86 💬 |
1029 |
Lisuride hydrogenmaleate |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1030 |
Lisuride transdermal system |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1031 |
Lisuride tts |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1032 |
Lisuride tts 10cm² |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1033 |
Lisuride tts 20cm² |
Lisuride |
[2] D01462 D01462, D08132 D08132 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1034 |
Lithium |
- |
- |
- |
- |
002 [5] 2 , 5 , 6 , 7 , 8 💬 |
1035 |
Lixisenatide |
Lixisenatide |
[1] D09729 D09729 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [1] 6 💬 |
1036 |
Local anesthesia (lidocaine hydrochloride) |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
1037 |
Local trade name, 2mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1038 |
Local trade name, 4mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1039 |
Local trade name, 8mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1040 |
Lodalès® |
- |
- |
- |
- |
006 [1] 6 💬 |
1041 |
Lodosyn® |
- |
- |
- |
- |
006 [1] 6 💬 |
1042 |
Lovastatin |
Lovastatin |
[1] D00359 D00359 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬 |
1043 |
Low dose affitope® pd03a + adjuvant |
- |
- |
- |
- |
006 [1] 6 💬 |
1044 |
Lu 00-800 |
- |
- |
- |
- |
006 [1] 6 💬 |
1045 |
Lu af28996 |
- |
- |
- |
- |
006 [1] 6 💬 |
1046 |
Lu af82422 |
- |
- |
- |
- |
006 [1] 6 💬 |
1047 |
Lubiprostone |
Lubiprostone |
[1] D04790 D04790 💬 |
CLCN2 [1] CLCN2 💬 |
Mineral absorption [1] Mineral absorption |
006 [4] 6 , 13, 290, 299 💬 |
1048 |
Ly03003 |
- |
- |
- |
- |
006 [1] 6 💬 |
1049 |
Ly03003 ( rotigotine, extended-release microspheres) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1050 |
Ly03003 (rotigotine extended release microspheres for intramuscular [im] injection) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1051 |
Ly03003( the name of rotigotine) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1052 |
Ly03003(rotigotine,extended-release microspheres) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1053 |
Ly03009 f1 |
- |
- |
- |
- |
006 [1] 6 💬 |
1054 |
Ly03009 f2 |
- |
- |
- |
- |
006 [1] 6 💬 |
1055 |
Ly03009 f3 |
- |
- |
- |
- |
006 [1] 6 💬 |
1056 |
Ly03009 f4 |
- |
- |
- |
- |
006 [1] 6 💬 |
1057 |
Ly300164 |
- |
- |
- |
- |
006 [1] 6 💬 |
1058 |
Ly3154207 |
- |
- |
- |
- |
006 [1] 6 💬 |
1059 |
Madopar |
- |
- |
- |
- |
006 [1] 6 💬 |
1060 |
Madopar 125 mg, orodispersible tablet |
- |
- |
- |
- |
006 [1] 6 💬 |
1061 |
Madopar 200+50 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1062 |
Madopar lt |
- |
- |
- |
- |
006 [1] 6 💬 |
1063 |
Madopar® 125 |
- |
- |
- |
- |
006 [1] 6 💬 |
1064 |
Madopar® 250 |
- |
- |
- |
- |
006 [1] 6 💬 |
1065 |
Madopar® hbs |
- |
- |
- |
- |
006 [1] 6 💬 |
1066 |
Madopar® hbs 125 |
- |
- |
- |
- |
006 [1] 6 💬 |
1067 |
Magnesium |
Magnesium |
- |
- |
- |
006 [16] 6 , 11, 13, 46, 64, 70, 93, 97, 166, 225, 235, 284, 291, 296, 297, 298 💬 |
1068 |
Magnesium oxide |
Magnesium |
[1] D01167 D01167 💬 |
- |
- |
006 [3] 6 , 166, 291 💬 |
1069 |
Maltodextrin |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
006 [4] 6 , 13, 96, 97 💬 |
1070 |
Mannitol |
Mannitol |
[1] D00062 D00062 💬 |
- |
- |
006 [4] 6 , 60, 96, 299 💬 |
1071 |
Mantadix |
- |
- |
- |
- |
006 [1] 6 💬 |
1072 |
Mars |
- |
- |
- |
- |
006 [1] 6 💬 |
1073 |
Masitinib |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
1074 |
Masitinib mesylate |
Masitinib |
[1] D10229 D10229 💬 |
KIT [1] KIT 💬 |
Acute myeloid leukemia [11] Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 [6] 2 , 5 , 6 , 13, 46, 96 💬 |
1075 |
Mavoglurant |
Mavoglurant |
- |
- |
- |
006 [2] 6 , 206 💬 |
1076 |
Mct |
- |
- |
- |
- |
006 [1] 6 💬 |
1077 |
Me2125 (safinamide mesilate) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1078 |
Medi1341 |
- |
- |
- |
- |
006 [1] 6 💬 |
1079 |
Melatonin |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [11] 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬 |
1080 |
Melatonin pr |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1081 |
Melatonin(circadin®) |
Melatonin |
[1] D08170 D08170 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1082 |
Melevodopa |
Melevodopa |
[1] D07304 D07304 💬 |
- |
- |
006 [1] 6 💬 |
1083 |
Melevodopa and decarboxylase inhibitor |
Melevodopa |
[1] D07304 D07304 💬 |
- |
- |
006 [1] 6 💬 |
1084 |
Melperon |
- |
- |
- |
- |
006 [1] 6 💬 |
1085 |
Melperone |
Melperone |
[1] D07309 D07309 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1086 |
Melperone hcl |
Melperone |
[1] D07309 D07309 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1087 |
Memantin orion |
- |
- |
- |
- |
006 [1] 6 💬 |
1088 |
Memantine |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [7] 2 , 6 , 8 , 13, 49, 127, 205 💬 |
1089 |
Memantine (drug) |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
1090 |
Memantine hydrochloride |
Memantine |
[2] D04905 D04905, D08174 D08174 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [3] 2 , 6 , 127 💬 |
1091 |
Mesdopetam |
Mesdopetam |
- |
- |
- |
006 [1] 6 💬 |
1092 |
Mesdopetam (irl790) |
Mesdopetam |
- |
- |
- |
006 [1] 6 💬 |
1093 |
Mesencephalic neuronal precursor cells |
- |
- |
- |
- |
006 [1] 6 💬 |
1094 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 [11] 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
1095 |
Mestinon |
- |
- |
- |
- |
003 [3] 3 , 6 , 11 💬 |
1096 |
Metabolic cofactor supplementation |
- |
- |
- |
- |
006 [1] 6 💬 |
1097 |
Metformin |
Metformin |
[2] D00944 D00944, D04966 D04966 💬 |
PRKAA1 [2] PRKAA1, PRKAA2 💬 |
AMPK signaling pathway [19] AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 [21] 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
1098 |
Methylphenidate |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [7] 6 , 13, 34, 84, 113, 179, 206 💬 |
1099 |
Methylphenidate (mpd) |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [1] 6 💬 |
1100 |
Methylphenidate hydrochloride |
Methylphenidate |
[2] D01296 D01296, D04999 D04999 💬 |
SLC6A2 [2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 [2] 6 , 13 💬 |
1101 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
1102 |
Mg |
- |
- |
- |
- |
006 [3] 6 , 13, 51 💬 |
1103 |
Mid dose anavex2-73 |
- |
- |
- |
- |
006 [1] 6 💬 |
1104 |
Midazolam |
Midazolam |
[3] D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
1105 |
Midodrine |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [3] 6 , 17, 58 💬 |
1106 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
1107 |
Minodronic acid |
Minodronic acid |
- |
- |
- |
006 [4] 6 , 46, 93, 95 💬 |
1108 |
Mirabegron |
Mirabegron |
[1] D09535 D09535 💬 |
ADRB3 [1] ADRB3 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway |
006 [3] 6 , 13, 226 💬 |
1109 |
Mirapex |
- |
- |
- |
- |
006 [1] 6 💬 |
1110 |
Mirapex (pramipexole) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1111 |
Mirapex er |
- |
- |
- |
- |
006 [1] 6 💬 |
1112 |
Mirapex la |
- |
- |
- |
- |
006 [1] 6 💬 |
1113 |
Mirapexin |
- |
- |
- |
- |
006 [1] 6 💬 |
1114 |
Mirapexin / sifrol |
- |
- |
- |
- |
006 [1] 6 💬 |
1115 |
Mirapexin extended release various strengths |
- |
- |
- |
- |
006 [1] 6 💬 |
1116 |
Mirapexin*30cpr 0,7mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1117 |
Mirapexin/sifrol |
- |
- |
- |
- |
006 [1] 6 💬 |
1118 |
Mitoq |
- |
- |
- |
- |
006 [3] 6 , 13, 97 💬 |
1119 |
Mk0657 |
- |
- |
- |
- |
006 [1] 6 💬 |
1120 |
Moclobemide |
Moclobemide |
[1] D02561 D02561 💬 |
MAOA [1] MAOA 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1121 |
Modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [4] 6 , 13, 49, 93 💬 |
1122 |
Modafinil 50mg |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [1] 6 💬 |
1123 |
Modal |
- |
- |
- |
- |
002 [5] 2 , 6 , 17, 46, 70 💬 |
1124 |
Modiodal |
- |
- |
- |
- |
006 [1] 6 💬 |
1125 |
Modopar |
- |
- |
- |
- |
006 [1] 6 💬 |
1126 |
Monoamine oxidase b inhibitors |
- |
- |
- |
- |
006 [1] 6 💬 |
1127 |
Motilium |
- |
- |
- |
- |
006 [2] 6 , 230 💬 |
1128 |
Moxifloxacin |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
1129 |
Moxifloxacin infusion |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
006 [1] 6 💬 |
1130 |
Moxifloxacina cloridrato |
- |
- |
- |
- |
006 [1] 6 💬 |
1131 |
Msc |
- |
- |
- |
- |
006 [6] 6 , 51, 60, 96, 97, 271 💬 |
1132 |
Muscimol |
Muscimol |
- |
- |
- |
006 [1] 6 💬 |
1133 |
Mémantine |
- |
- |
- |
- |
006 [1] 6 💬 |
1134 |
N acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [2] 6 , 19 💬 |
1135 |
N-0923 |
- |
- |
- |
- |
006 [1] 6 💬 |
1136 |
N-acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [10] 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
1137 |
N-acetylcysteine capsule |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [1] 6 💬 |
1138 |
N.a. |
- |
- |
- |
- |
003 [10] 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
1139 |
N04bd02 |
- |
- |
- |
- |
006 [1] 6 💬 |
1140 |
Nabilone |
Nabilone |
[1] D05099 D05099 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [2] 6 , 13 💬 |
1141 |
Nabilone 0.25 mg |
Nabilone |
[1] D05099 D05099 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [1] 6 💬 |
1142 |
Nacom |
- |
- |
- |
- |
006 [1] 6 💬 |
1143 |
Nacom 100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1144 |
Nacom levodopa+cardidopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1145 |
Nal |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
1146 |
Nalmefene |
Nalmefene |
[1] D05111 D05111 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1147 |
Naloxone |
Naloxone |
[2] D01340 D01340, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [2] 6 , 226 💬 |
1148 |
Naloxone hydrochloride dihydrate |
Naloxone |
[2] D01340 D01340, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1149 |
Naltrexone |
Naltrexone |
[2] D02095 D02095, D05113 D05113 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [12] 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
1150 |
Nardil |
- |
- |
- |
- |
006 [1] 6 💬 |
1151 |
Nbtx-001 |
- |
- |
- |
- |
006 [1] 6 💬 |
1152 |
Nd0611 |
- |
- |
- |
- |
006 [1] 6 💬 |
1153 |
Nd0612 |
- |
- |
- |
- |
006 [1] 6 💬 |
1154 |
Nd0612 (levodopa/carbidopa solution) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1155 |
Nd1421 |
- |
- |
- |
- |
006 [1] 6 💬 |
1156 |
Nd1587 |
- |
- |
- |
- |
006 [1] 6 💬 |
1157 |
Nd1589 |
- |
- |
- |
- |
006 [1] 6 💬 |
1158 |
Nd1590 |
- |
- |
- |
- |
006 [1] 6 💬 |
1159 |
Nd1702 |
- |
- |
- |
- |
006 [1] 6 💬 |
1160 |
Nebicapone |
Nebicapone |
- |
- |
- |
006 [1] 6 💬 |
1161 |
Nelotanserin |
Nelotanserin |
[1] D09645 D09645 💬 |
HTR2A [1] HTR2A 💬 |
Calcium signaling pathway [5] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse |
006 [1] 6 💬 |
1162 |
Neridronic acid |
Neridronic Acid |
- |
- |
- |
006 [1] 6 💬 |
1163 |
Nerixia*im ev 1f 25mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1164 |
Neu-120 |
- |
- |
- |
- |
006 [1] 6 💬 |
1165 |
Neupro |
- |
- |
- |
- |
006 [1] 6 💬 |
1166 |
Neupro (reference) |
- |
- |
- |
- |
006 [1] 6 💬 |
1167 |
Neupro 2 mg/24 h parche transdérmico |
- |
- |
- |
- |
006 [1] 6 💬 |
1168 |
Neupro 2 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1169 |
Neupro 2mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1170 |
Neupro 2mg/24h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1171 |
Neupro 4 mg/24 h parche transdérmico |
- |
- |
- |
- |
006 [1] 6 💬 |
1172 |
Neupro 4 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1173 |
Neupro 4mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1174 |
Neupro 4mg/24h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1175 |
Neupro 4mg/24hr transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1176 |
Neupro 6 mg/24 h parche transdérmico |
- |
- |
- |
- |
006 [1] 6 💬 |
1177 |
Neupro 6 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1178 |
Neupro 6mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1179 |
Neupro 6mg/24h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1180 |
Neupro 8 mg/24 h parche transdérmico |
- |
- |
- |
- |
006 [1] 6 💬 |
1181 |
Neupro 8 mg/24 h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1182 |
Neupro 8mg/24h transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1183 |
Neupro*28cer 2mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1184 |
Neupro*28cer 4mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1185 |
Neupro*28cer 6mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1186 |
Neupro*28cer 8mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1187 |
Neupro*7cer 4mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1188 |
Neupro*7cer 6mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1189 |
Neupro*7cer 8mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1190 |
Neupro® |
- |
- |
- |
- |
006 [1] 6 💬 |
1191 |
Neuraceq |
- |
- |
- |
- |
006 [1] 6 💬 |
1192 |
Neurobloc |
- |
- |
- |
- |
006 [1] 6 💬 |
1193 |
Neuroepo |
- |
- |
- |
- |
006 [1] 6 💬 |
1194 |
Neurohormonal mechanisms |
- |
- |
- |
- |
006 [2] 6 , 127 💬 |
1195 |
Neurpro |
- |
- |
- |
- |
006 [1] 6 💬 |
1196 |
Niacin |
Niacin |
[1] D00049 D00049 💬 |
- |
- |
006 [3] 6 , 78, 265 💬 |
1197 |
Niacinamide |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
005 [4] 5 , 6 , 13, 67 💬 |
1198 |
Nicorette 10mg/ 16 h |
- |
- |
- |
- |
006 [1] 6 💬 |
1199 |
Nicorette 15 mg/ 16 h |
- |
- |
- |
- |
006 [1] 6 💬 |
1200 |
Nicorette 5 mg/ 16 h |
- |
- |
- |
- |
006 [1] 6 💬 |
1201 |
Nicotinamide |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
002 [6] 2 , 6 , 18, 49, 162, 191 💬 |
1202 |
Nicotinamide riboside |
Nicotinamide |
[1] D00036 D00036 💬 |
- |
- |
002 [4] 2 , 6 , 18, 191 💬 |
1203 |
Nicotine |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [2] 6 , 84 💬 |
1204 |
Nicotine gum |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
1205 |
Nicotine nasal spray 10 mg/ml (0.5 mg/spray) |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
1206 |
Nicotine patch |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [2] 6 , 84 💬 |
1207 |
Nicotine transdermal patch |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
1208 |
Nicotinell |
- |
- |
- |
- |
006 [1] 6 💬 |
1209 |
Nicotinell 17,5 mg/24-stunden-pflaster |
- |
- |
- |
- |
006 [1] 6 💬 |
1210 |
Nicotinell 35 mg/24-stunden-pflaster |
- |
- |
- |
- |
006 [1] 6 💬 |
1211 |
Nilotinib |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [5] 6 , 8 , 34, 51, 86 💬 |
1212 |
Nilotinib 150mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
1213 |
Nilotinib 300mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
1214 |
Nitrogen |
Nitrogen |
[1] D00083 D00083 💬 |
- |
- |
005 [6] 5 , 6 , 17, 171, 211, 299 💬 |
1215 |
Nly01 |
- |
- |
- |
- |
006 [1] 6 💬 |
1216 |
Nmda |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
1217 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
1218 |
Northera |
- |
- |
- |
- |
006 [1] 6 💬 |
1219 |
Nortriptyline |
Nortriptyline |
[2] D00816 D00816, D08288 D08288 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 226 💬 |
1220 |
Nortriptyline hydrochloride |
Nortriptyline |
[2] D00816 D00816, D08288 D08288 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
1221 |
Npc transplantation |
- |
- |
- |
- |
006 [1] 6 💬 |
1222 |
Nr2b nmda antagonist cp-101,606 (traxoprodil) |
Ketamine |
[2] D00711 D00711, D08098 D08098 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
1223 |
Ns 2330 |
- |
- |
- |
- |
006 [1] 6 💬 |
1224 |
Ns2330 |
- |
- |
- |
- |
006 [1] 6 💬 |
1225 |
Nt 101 |
- |
- |
- |
- |
005 [4] 5 , 6 , 7 , 17 💬 |
1226 |
Ntcell implantation |
- |
- |
- |
- |
006 [1] 6 💬 |
1227 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
1228 |
Nw-1015 |
- |
- |
- |
- |
006 [1] 6 💬 |
1229 |
Nw-1015e, emd 1195686, msc2191632b |
- |
- |
- |
- |
006 [1] 6 💬 |
1230 |
Nyx-458 |
- |
- |
- |
- |
006 [1] 6 💬 |
1231 |
Oc oral solution treatment a |
- |
- |
- |
- |
006 [1] 6 💬 |
1232 |
Oc oral solution treatment b |
- |
- |
- |
- |
006 [1] 6 💬 |
1233 |
Oc oral solution treatment c |
- |
- |
- |
- |
006 [1] 6 💬 |
1234 |
Oc oral solution treatment d |
- |
- |
- |
- |
006 [1] 6 💬 |
1235 |
Odm-101 |
- |
- |
- |
- |
006 [1] 6 💬 |
1236 |
Odm-101 105mg carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1237 |
Odm-101 65mg carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1238 |
Odm-104 |
- |
- |
- |
- |
006 [1] 6 💬 |
1239 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
1240 |
Onabotulinumtoxin a injection |
- |
- |
- |
- |
006 [1] 6 💬 |
1241 |
Onabotulinumtoxina |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
006 [3] 6 , 13, 226 💬 |
1242 |
Ondansetron |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [3] 6 , 97, 231 💬 |
1243 |
Ondansetron 8 mg film-coated tablets |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1244 |
Ondansetron hydrochloride dihydrate |
Ondansetron |
[2] D00456 D00456, D00678 D00678 💬 |
HTR3A [5] HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 |
Serotonergic synapse [2] Serotonergic synapse, Taste transduction |
006 [2] 6 , 97 💬 |
1245 |
Ongentys |
- |
- |
- |
- |
006 [1] 6 💬 |
1246 |
Ono-2160/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
1247 |
Ono-2370 |
- |
- |
- |
- |
006 [1] 6 💬 |
1248 |
Ono-2506po |
- |
- |
- |
- |
002 [2] 2 , 6 💬 |
1249 |
Opc |
- |
- |
- |
- |
006 [1] 6 💬 |
1250 |
Opicapone |
Opicapone |
[1] D10825 D10825 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1251 |
Opicapone (opc) |
Opicapone |
[1] D10825 D10825 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1252 |
Optimal drug therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
1253 |
Optimized antiparkinsonian treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1254 |
Oral escitalopram |
Escitalopram |
[3] D02567 D02567, D07704 D07704, D07913 D07913 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [1] 6 💬 |
1255 |
Oral levodopa and carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1256 |
Oral levodopa/carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1257 |
Orally disintegrating selegiline (zelapar) |
Selegiline |
[2] D00785 D00785, D03731 D03731 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1258 |
Osu 6162 similar to (-)-osu 6162 |
- |
- |
- |
- |
006 [1] 6 💬 |
1259 |
Osu6162 similar to (-)-osu 6162 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
1260 |
Other nervous system drugs |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1261 |
Other parkinson's disease treatments |
- |
- |
- |
- |
006 [1] 6 💬 |
1262 |
Other: [11c]donepezil pet |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1263 |
Other: balance |
Isoxaflutole |
- |
- |
- |
006 [3] 6 , 13, 299 💬 |
1264 |
Other: balance exercise |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1265 |
Other: balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1266 |
Other: berg balance scale |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1267 |
Other: best medical treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1268 |
Other: collection of csf, blood, urine, saliva |
- |
- |
- |
- |
006 [1] 6 💬 |
1269 |
Other: computer game based balance and walking rehabilitation for individuals with parkinson's disease |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1270 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
1271 |
Other: controlled environment tests (series of tasks of everyday life) |
- |
- |
- |
- |
006 [1] 6 💬 |
1272 |
Other: controls primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1273 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 [1] 6 💬 |
1274 |
Other: diary completion |
- |
- |
- |
- |
006 [1] 6 💬 |
1275 |
Other: dyt 1 dystonia |
- |
- |
- |
- |
006 [1] 6 💬 |
1276 |
Other: dyt 1 dystonia (healthy control) |
- |
- |
- |
- |
006 [1] 6 💬 |
1277 |
Other: endurance |
- |
- |
- |
- |
006 [1] 6 💬 |
1278 |
Other: evaluation by investigator |
- |
- |
- |
- |
006 [1] 6 💬 |
1279 |
Other: event-related evoked potential using electroencephalography (eeg). |
- |
- |
- |
- |
006 [1] 6 💬 |
1280 |
Other: fog |
- |
- |
- |
- |
006 [1] 6 💬 |
1281 |
Other: four square step test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1282 |
Other: functional mobility |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1283 |
Other: functional reach test |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1284 |
Other: gait and balance group training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1285 |
Other: hemicellulose crystalline |
- |
- |
- |
- |
006 [1] 6 💬 |
1286 |
Other: high intensity exercise and balance training |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1287 |
Other: hoehn and yahr scale |
- |
- |
- |
- |
006 [1] 6 💬 |
1288 |
Other: imitation surgical procedure (isp) |
- |
- |
- |
- |
006 [1] 6 💬 |
1289 |
Other: lower limb strength |
- |
- |
- |
- |
006 [1] 6 💬 |
1290 |
Other: mibg label with i123 or i124 |
- |
- |
- |
- |
006 [1] 6 💬 |
1291 |
Other: mobile platform exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
1292 |
Other: motor assessments before taking regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1293 |
Other: motor assessments on regular pd treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1294 |
Other: mp+ddci |
- |
- |
- |
- |
006 [1] 6 💬 |
1295 |
Other: mp-equivalent |
- |
- |
- |
- |
006 [1] 6 💬 |
1296 |
Other: mp-low |
- |
- |
- |
- |
006 [1] 6 💬 |
1297 |
Other: mri |
- |
- |
- |
- |
006 [3] 6 , 127, 206 💬 |
1298 |
Other: multidisciplinary intensive rehabilitation treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1299 |
Other: music |
- |
- |
- |
- |
006 [1] 6 💬 |
1300 |
Other: neupro 4 mg / 24 hr. transdermal patch |
- |
- |
- |
- |
006 [1] 6 💬 |
1301 |
Other: non-motor symptoms |
- |
- |
- |
- |
006 [1] 6 💬 |
1302 |
Other: nordic walking (only osteoporosis group) |
- |
- |
- |
- |
006 [1] 6 💬 |
1303 |
Other: observational cohort |
- |
- |
- |
- |
006 [1] 6 💬 |
1304 |
Other: optional blood-oxygen-level dependent functionalmri |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [1] 6 💬 |
1305 |
Other: parkinson mpower mobile application |
- |
- |
- |
- |
006 [1] 6 💬 |
1306 |
Other: pd exercise intervention |
- |
- |
- |
- |
006 [1] 6 💬 |
1307 |
Other: pd vitamin + exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
1308 |
Other: physical function performance test |
- |
- |
- |
- |
006 [1] 6 💬 |
1309 |
Other: physical therapy |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
1310 |
Other: pittsburgh compound b [11c]-pib |
Pittsburgh Compound B |
- |
- |
- |
006 [1] 6 💬 |
1311 |
Other: questionnaires |
- |
- |
- |
- |
006 [5] 6 , 13, 41, 93, 96 💬 |
1312 |
Other: recommendation with regard to nutrition |
- |
- |
- |
- |
006 [1] 6 💬 |
1313 |
Other: rhythmic auditory stimulation (ras) |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1314 |
Other: rhythmic balance-movement training (rbmt) |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1315 |
Other: rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1316 |
Other: saline |
- |
- |
- |
- |
002 [8] 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
1317 |
Other: screening to prevent falls |
- |
- |
- |
- |
006 [1] 6 💬 |
1318 |
Other: sham group |
- |
- |
- |
- |
006 [1] 6 💬 |
1319 |
Other: sham surgery |
- |
- |
- |
- |
006 [1] 6 💬 |
1320 |
Other: smartphone-based balance exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1321 |
Other: specific sl-therapy |
- |
- |
- |
- |
006 [1] 6 💬 |
1322 |
Other: standardized scales: mds-updrs (part ii to iv) and rdrs |
- |
- |
- |
- |
006 [1] 6 💬 |
1323 |
Other: stool sample |
- |
- |
- |
- |
006 [2] 6 , 299 💬 |
1324 |
Other: t-dcs group |
- |
- |
- |
- |
006 [1] 6 💬 |
1325 |
Other: tampa kinesiophobia scale, berg-balance test, international physical activity questionnaire-short form, falls efficacy scale |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1326 |
Other: the timed 360° turn test |
- |
- |
- |
- |
006 [1] 6 💬 |
1327 |
Other: timed up and go test |
- |
- |
- |
- |
006 [1] 6 💬 |
1328 |
Other: trunk impairment scale |
- |
- |
- |
- |
006 [1] 6 💬 |
1329 |
Other: tyramine |
Tyramine |
- |
- |
- |
006 [1] 6 💬 |
1330 |
Other: unified parkinson's disease rating scale |
- |
- |
- |
- |
006 [1] 6 💬 |
1331 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
1332 |
Other: usual drug treatment of parkinson's disease |
- |
- |
- |
- |
006 [1] 6 💬 |
1333 |
Other: voluntary cough test |
- |
- |
- |
- |
006 [1] 6 💬 |
1334 |
Over-encapsulated entacapone tablets |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1335 |
Over-encapsulated modafinil |
Modafinil |
[1] D01832 D01832 💬 |
- |
- |
006 [1] 6 💬 |
1336 |
Oxaloacetate (oaa) |
- |
- |
- |
- |
006 [1] 6 💬 |
1337 |
Oxb-102 |
- |
- |
- |
- |
006 [1] 6 💬 |
1338 |
Oxn 10 mg / 5 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
1339 |
Oxn 20 mg / 10 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
1340 |
Oxn 5 mg/2.5 mg pr |
- |
- |
- |
- |
006 [1] 6 💬 |
1341 |
Oxybate |
gamma-Hydroxybutyric acid |
- |
- |
- |
006 [2] 6 , 149 💬 |
1342 |
Oxybuprocaine |
Oxybuprocaine |
[2] D01768 D01768, D08319 D08319 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [1] 6 💬 |
1343 |
Oxybutynin |
Oxybutynin |
[2] D00465 D00465, D00722 D00722 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1344 |
Oxybutynin and darifenacin |
Darifenacin |
[4] D00465 D00465, D00722 D00722, D01699 D01699, D03654 D03654 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1345 |
Oxybutynin hydrochloride |
Oxybutynin |
[2] D00465 D00465, D00722 D00722 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1346 |
Oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [7] 6 , 13, 46, 70, 226, 231, 298 💬 |
1347 |
Oxycodone hydrochloride |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [4] 6 , 70, 226, 298 💬 |
1348 |
Oxycodone/naloxone prolonged release tablets |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1349 |
Oxycodone/naloxone prolonged release tablets 10 mg /5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1350 |
Oxycodone/naloxone prolonged release tablets 20 mg /10 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1351 |
Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg |
Naloxone |
[5] D01340 D01340, D03783 D03783, D05312 D05312, D05462 D05462, D08249 D08249 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1352 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
1353 |
Oxytocin |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 [5] 6 , 127, 193, 206, 226 💬 |
1354 |
Oxytocin synthetic |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1355 |
P2b001 |
- |
- |
- |
- |
006 [1] 6 💬 |
1356 |
P2b001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), |
Pramipexole |
[5] D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 [4] DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism [18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1357 |
P2b001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), |
Pramipexole |
[5] D00559 D00559, D02562 D02562, D05575 D05575, D08469 D08469, D10829 D10829 💬 |
DRD2 [4] DRD2, DRD3, DRD4, MAOB 💬 |
Alcoholism [18] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1358 |
Paracetamol |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
003 [5] 3 , 6 , 13, 35, 46 💬 |
1359 |
Parapres |
- |
- |
- |
- |
006 [1] 6 💬 |
1360 |
Parcopa |
- |
- |
- |
- |
006 [1] 6 💬 |
1361 |
Pardaprunox |
- |
- |
- |
- |
006 [1] 6 💬 |
1362 |
Pardoprunox |
Pardoprunox |
[1] D09397 D09397 💬 |
DRD2 [3] DRD2, DRD3, HTR1A 💬 |
Alcoholism [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1363 |
Pardoprunox hydrochloride |
Pardoprunox |
[1] D09397 D09397 💬 |
DRD2 [3] DRD2, DRD3, HTR1A 💬 |
Alcoholism [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1364 |
Paroxetine |
Paroxetine |
[4] D02260 D02260, D02362 D02362, D05374 D05374, D05375 D05375 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [3] 6 , 13, 46 💬 |
1365 |
Part 1, jm-010 component group a |
- |
- |
- |
- |
006 [1] 6 💬 |
1366 |
Part 1, jm-010 component group b |
- |
- |
- |
- |
006 [1] 6 💬 |
1367 |
Part 1, jm-010 component group c |
- |
- |
- |
- |
006 [1] 6 💬 |
1368 |
Part 2, jm-010 combination group a |
- |
- |
- |
- |
006 [1] 6 💬 |
1369 |
Part 2, jm-010 combination group b |
- |
- |
- |
- |
006 [1] 6 💬 |
1370 |
Part 2, jm-010 component group c |
- |
- |
- |
- |
006 [1] 6 💬 |
1371 |
Pat |
- |
- |
- |
- |
006 [3] 6 , 13, 160 💬 |
1372 |
Pbf-509 |
- |
- |
- |
- |
006 [1] 6 💬 |
1373 |
Pd patients h&y=1.5-2 medications off |
- |
- |
- |
- |
006 [1] 6 💬 |
1374 |
Pd patients h&y=1.5-2 medications on |
- |
- |
- |
- |
006 [1] 6 💬 |
1375 |
Pd patients h&y=3 medications off |
- |
- |
- |
- |
006 [1] 6 💬 |
1376 |
Pd patients h&y=3 medications on |
- |
- |
- |
- |
006 [1] 6 💬 |
1377 |
Pd vitamin supplementation |
- |
- |
- |
- |
006 [1] 6 💬 |
1378 |
Peg |
- |
- |
- |
- |
006 [9] 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
1379 |
Perampanel |
Perampanel |
[1] D08964 D08964 💬 |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [3] 2 , 6 , 144 💬 |
1380 |
Pergolide |
Pergolide |
[2] D00502 D00502, D08339 D08339 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1381 |
Pet |
- |
- |
- |
- |
006 [1] 6 💬 |
1382 |
Pf-06412562 |
- |
- |
- |
- |
006 [1] 6 💬 |
1383 |
Pf-06649751 |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1384 |
Pf-06649751 - 15mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1385 |
Pf-06649751 - 1mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1386 |
Pf-06649751 - 5mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1387 |
Pf-06649751 high dose (15 mg qd) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1388 |
Pf-06649751 low dose (1 mg qd) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1389 |
Pf-06649751 middle dose 1 (3 mg qd) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1390 |
Pf-06649751 middle dose 2 (7 mg qd) |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1391 |
Pf-06669571 |
- |
- |
- |
- |
006 [1] 6 💬 |
1392 |
Ph. eur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [1] 6 💬 |
1393 |
Ph. eur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid |
- |
- |
- |
- |
006 [1] 6 💬 |
1394 |
Phenlarmide tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1395 |
Phenylbutyrate |
Phenylbutyric acid |
[1] D05868 D05868 💬 |
- |
- |
002 [11] 2 , 3 , 6 , 8 , 15, 93, 94, 244, 251, 297, 299 💬 |
1396 |
Pheur.: (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [1] 6 💬 |
1397 |
Pheur.: (2s)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid |
- |
- |
- |
- |
006 [1] 6 💬 |
1398 |
Piclozotan |
Piclozotan |
- |
- |
- |
006 [1] 6 💬 |
1399 |
Pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [3] 6 , 53, 299 💬 |
1400 |
Pimavanserin |
Pimavanserin |
- |
- |
- |
006 [1] 6 💬 |
1401 |
Pimavanserin (acp-103) |
Pimavanserin |
- |
- |
- |
006 [1] 6 💬 |
1402 |
Pimavanserin tartrate |
Pimavanserin |
- |
- |
- |
006 [1] 6 💬 |
1403 |
Pimavanserin tartrate (acp-103) |
Pimavanserin |
- |
- |
- |
006 [1] 6 💬 |
1404 |
Pioglitazone |
Pioglitazone |
[2] D00945 D00945, D08378 D08378 💬 |
PPARG [1] PPARG 💬 |
AMPK signaling pathway [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 [17] 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
1405 |
Piribedil |
Piribedil |
[1] D07305 D07305 💬 |
DRD2 [2] DRD2, DRD3 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1406 |
Piribedil (clarium) |
Piribedil |
[1] D07305 D07305 💬 |
DRD2 [2] DRD2, DRD3 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1407 |
Pitolisant |
Pitolisant |
[1] D10749 D10749 💬 |
HRH3 [1] HRH3 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [2] 6 , 193 💬 |
1408 |
Pittsburgh compound b |
Pittsburgh Compound B |
- |
- |
- |
006 [2] 6 , 127 💬 |
1409 |
Pk-merz |
- |
- |
- |
- |
006 [1] 6 💬 |
1410 |
Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
1411 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
1412 |
Plantago ovata husk |
- |
- |
- |
- |
006 [1] 6 💬 |
1413 |
Posiphen |
Posiphen |
- |
- |
- |
006 [1] 6 💬 |
1414 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
1415 |
Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin) |
- |
- |
- |
- |
006 [1] 6 💬 |
1416 |
Pr oxycodone |
Oxycodone |
[3] D03783 D03783, D05312 D05312, D05462 D05462 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1417 |
Pr001a |
- |
- |
- |
- |
006 [1] 6 💬 |
1418 |
Pramipexol |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1419 |
Pramipexol extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1420 |
Pramipexol immediate release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1421 |
Pramipexole |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [2] 2 , 6 💬 |
1422 |
Pramipexole 0.125 mg tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1423 |
Pramipexole 0.5 mg tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1424 |
Pramipexole dihydrochloride |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1425 |
Pramipexole dihydrochloride extended-release tablets |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1426 |
Pramipexole dihydrochloride monohydrate |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1427 |
Pramipexole dihydrochloride monohydrate extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1428 |
Pramipexole er |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1429 |
Pramipexole extended release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1430 |
Pramipexole extended release tablet |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1431 |
Pramipexole hydrochloride sustained-release tablet (siforl®) specification: 0.26mg/ tablet (in pramipexole) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1432 |
Pramipexole immediate release |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1433 |
Pramipexole immediate release tablet |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1434 |
Pramipexole ir |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1435 |
Pramipexole or ropinirole |
Pramipexole |
[4] D00559 D00559, D00784 D00784, D05575 D05575, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1436 |
Pramipexole sr |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1437 |
Praxol hydrochloride sustained release tablet specification: 0.375mg/ tablet (in pramipexole hydrochloride) |
Pramipexole |
[2] D00559 D00559, D05575 D05575 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1438 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
1439 |
Preladenant |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1440 |
Preladenant 10 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1441 |
Preladenant 2 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1442 |
Preladenant 5 mg tablet |
Preladenant |
[1] D09717 D09717 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1443 |
Premarin ® |
- |
- |
- |
- |
006 [1] 6 💬 |
1444 |
Pridia (donepezil hydrochloride) 5mg |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1445 |
Pridia 10mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1446 |
Pridia 5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1447 |
Pridopidine |
Pridopidine |
[1] D09953 D09953 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [3] 2 , 6 , 8 💬 |
1448 |
Prim-dj2727 |
- |
- |
- |
- |
006 [2] 6 , 97 💬 |
1449 |
Primary cervical dystonia (trihexyphenidyl) |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1450 |
Primavanserin tartrate |
- |
- |
- |
- |
006 [1] 6 💬 |
1451 |
Prior donepezil 5mg |
Donepezil |
[2] D00670 D00670, D07869 D07869 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1452 |
Prior donzepezil 10mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1453 |
Probiotic |
- |
- |
- |
- |
002 [7] 2 , 6 , 93, 96, 97, 193, 266 💬 |
1454 |
Probiotic capsule |
- |
- |
- |
- |
006 [1] 6 💬 |
1455 |
Probiotics with prebiotic |
- |
- |
- |
- |
006 [1] 6 💬 |
1456 |
Procedure: [123i]-ibzm imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
1457 |
Procedure: [123i]beta-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
1458 |
Procedure: [123i]ß-cit and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
1459 |
Procedure: biofluid samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
1460 |
Procedure: blood analysis |
- |
- |
- |
- |
006 [1] 6 💬 |
1461 |
Procedure: blood draw |
- |
- |
- |
- |
006 [5] 6 , 19, 65, 231, 299 💬 |
1462 |
Procedure: cardiac monitoring |
- |
- |
- |
- |
006 [1] 6 💬 |
1463 |
Procedure: datscan and spect imaging |
- |
- |
- |
- |
006 [1] 6 💬 |
1464 |
Procedure: electroacupuncture |
- |
- |
- |
- |
006 [2] 6 , 70 💬 |
1465 |
Procedure: embryonic dopamine cell implant surgery |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1466 |
Procedure: exergame |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1467 |
Procedure: fluoroscopic swallow evaluation |
- |
- |
- |
- |
006 [1] 6 💬 |
1468 |
Procedure: home based balance training |
Isoxaflutole |
- |
- |
- |
006 [2] 6 , 13 💬 |
1469 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 [5] 6 , 13, 19, 96, 97 💬 |
1470 |
Procedure: meg |
- |
- |
- |
- |
006 [1] 6 💬 |
1471 |
Procedure: motion analysis |
- |
- |
- |
- |
006 [1] 6 💬 |
1472 |
Procedure: percutaneous endoscopic gastrostomy with jejunal extension (peg-j) |
- |
- |
- |
- |
006 [1] 6 💬 |
1473 |
Procedure: pet/ct |
- |
- |
- |
- |
006 [1] 6 💬 |
1474 |
Procedure: physical exam and updrs part iii assessment |
- |
- |
- |
- |
006 [1] 6 💬 |
1475 |
Procedure: sedation with iv propofol |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1476 |
Procedure: sham surgery |
- |
- |
- |
- |
006 [1] 6 💬 |
1477 |
Procedure: static, dynamic and functional balance exercises |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1478 |
Procedure: static, dynamic and functional balance exercises with dual task |
Isoxaflutole |
- |
- |
- |
006 [1] 6 💬 |
1479 |
Procedure: tissue samplings |
- |
- |
- |
- |
006 [1] 6 💬 |
1480 |
Procedure: umbilical cord blood therapy |
Umbilical Cord Blood Hematopoietic Stem Cells |
- |
- |
- |
002 [2] 2 , 6 💬 |
1481 |
Prolonged release tablet |
- |
- |
- |
- |
006 [1] 6 💬 |
1482 |
Prolopa® |
- |
- |
- |
- |
006 [1] 6 💬 |
1483 |
Propanoic acid |
Propanoic acid |
[1] D02310 D02310 💬 |
- |
- |
006 [2] 6 , 271 💬 |
1484 |
Propofol |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [8] 6 , 21, 22, 34, 46, 84, 98, 296 💬 |
1485 |
Propofol-lipuro |
Propofol |
[1] D00549 D00549 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1486 |
Propranolol |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 158, 167, 227, 278 💬 |
1487 |
Propranolol hcl cf 40 mg tablet |
Propranolol |
[2] D00483 D00483, D08443 D08443 💬 |
ADRB1 [3] ADRB1, ADRB2, ADRB3 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1488 |
Prosavin |
- |
- |
- |
- |
006 [1] 6 💬 |
1489 |
Proscar*30cpr riv 5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1490 |
Prx002 |
- |
- |
- |
- |
006 [1] 6 💬 |
1491 |
Prx002, elt2, anti-alpha-synuclein monoclonal antibody |
- |
- |
- |
- |
006 [1] 6 💬 |
1492 |
Pt320 2.0 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1493 |
Pt320 2.5 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1494 |
Pxt002331 |
- |
- |
- |
- |
006 [1] 6 💬 |
1495 |
Pxt002331 - 20mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1496 |
Pxt002331 - dose 1 |
- |
- |
- |
- |
006 [1] 6 💬 |
1497 |
Pxt002331 - dose 2 |
- |
- |
- |
- |
006 [1] 6 💬 |
1498 |
Pym50028 |
- |
- |
- |
- |
006 [1] 6 💬 |
1499 |
Pyridostigmine |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [4] 3 , 6 , 11, 256 💬 |
1500 |
Pyridostigmine bromide |
Pyridostigmine |
[1] D00487 D00487 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
003 [3] 3 , 6 , 256 💬 |
1501 |
Quetiapine |
Quetiapine |
[2] D00458 D00458, D08456 D08456 💬 |
DRD2 [2] DRD2, HTR2A 💬 |
Alcoholism [11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
006 [2] 6 , 13 💬 |
1502 |
R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride |
Benzofuran |
- |
- |
- |
006 [1] 6 💬 |
1503 |
R-methugdnf |
Liatermin |
[1] D04727 D04727 💬 |
- |
- |
006 [1] 6 💬 |
1504 |
Raav-gad |
- |
- |
- |
- |
006 [1] 6 💬 |
1505 |
Raclopride |
Raclopride |
- |
- |
- |
005 [4] 5 , 6 , 7 , 17 💬 |
1506 |
Racol |
- |
- |
- |
- |
006 [3] 6 , 96, 291 💬 |
1507 |
Radiation: [18-fluorine] flubatine pet scan |
- |
- |
- |
- |
006 [1] 6 💬 |
1508 |
Radiation: fluoroscopy |
- |
- |
- |
- |
006 [1] 6 💬 |
1509 |
Radiation: h215o pet |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
1510 |
Radiation: pet with the tracer 11c-pe2i |
- |
- |
- |
- |
006 [1] 6 💬 |
1511 |
Radiation: pet with the tracer 18f-dpa-714 |
- |
- |
- |
- |
006 [1] 6 💬 |
1512 |
Radiation: radiosurgical thalamotomy |
- |
- |
- |
- |
006 [1] 6 💬 |
1513 |
Radiation: videofluoroscopic swallow evaluation |
- |
- |
- |
- |
006 [1] 6 💬 |
1514 |
Ramelteon |
Ramelteon |
[1] D02689 D02689 💬 |
MTNR1A [2] MTNR1A, MTNR1B 💬 |
Circadian entrainment [2] Circadian entrainment, Neuroactive ligand-receptor interaction |
006 [3] 6 , 8 , 46 💬 |
1515 |
Ras |
- |
- |
- |
- |
006 [3] 6 , 13, 66 💬 |
1516 |
Rasagilin |
- |
- |
- |
- |
005 [2] 5 , 6 💬 |
1517 |
Rasagilina |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
1518 |
Rasagilina mesilato |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
1519 |
Rasagilina mesilato (12 weeks) |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1520 |
Rasagiline |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [4] 2 , 5 , 6 , 17 💬 |
1521 |
Rasagiline 1 mg capsule |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1522 |
Rasagiline 1mg tablet |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1523 |
Rasagiline 2 mg tablet |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1524 |
Rasagiline mesilate |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [3] 2 , 5 , 6 💬 |
1525 |
Rasagiline mesylate |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
1526 |
Rasagiline mesylate 1.0 mg |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1527 |
Rasagiline mesylate plus mirapex |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1528 |
Rasagiline mesylate with levodopa |
Levodopa |
[4] D00059 D00059, D02562 D02562, D08469 D08469, D10829 D10829 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 |
Alcoholism [20] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1529 |
Rasagiline mesylate with requip |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1530 |
Rasagiline tablets |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1531 |
Recombinant human cerebral dopamine neurotrophic factor |
Dopamine |
[2] D00633 D00633, D07870 D07870 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1532 |
Recombinant-methionyl human glial cell line-derived neurotrophic factor |
- |
- |
- |
- |
006 [1] 6 💬 |
1533 |
Reduced glutathione |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
006 [2] 6 , 299 💬 |
1534 |
Reduced glutathione 100mg |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
006 [1] 6 💬 |
1535 |
Reduced glutathione 200mg |
Glutathione |
[2] D00014 D00014, D00031 D00031 💬 |
- |
- |
006 [1] 6 💬 |
1536 |
Regular novolin r |
- |
- |
- |
- |
006 [1] 6 💬 |
1537 |
Remifentanil |
Remifentanil |
[2] D01177 D01177, D08473 D08473 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
006 [2] 6 , 70 💬 |
1538 |
Remifentanyl |
Remifentanil |
[2] D01177 D01177, D08473 D08473 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1539 |
Reminyl |
- |
- |
- |
- |
006 [1] 6 💬 |
1540 |
Reminyl retard |
- |
- |
- |
- |
006 [1] 6 💬 |
1541 |
Repaglinide |
Repaglinide |
[1] D00594 D00594 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
006 [3] 6 , 21, 299 💬 |
1542 |
Requip |
- |
- |
- |
- |
006 [2] 6 , 309 💬 |
1543 |
Requip 21 cpr 0,25 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1544 |
Requip 21 cpr 0,5 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1545 |
Requip 21 cpr 1 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1546 |
Requip 21 cpr 2 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1547 |
Requip cr |
- |
- |
- |
- |
002 [2] 2 , 6 💬 |
1548 |
Requip modutab, 2mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1549 |
Requip modutab, 4mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1550 |
Requip modutab, 8mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1551 |
Requip pr |
- |
- |
- |
- |
006 [1] 6 💬 |
1552 |
Requip prolonged release |
- |
- |
- |
- |
006 [1] 6 💬 |
1553 |
Requip xl prolonged-release |
- |
- |
- |
- |
006 [1] 6 💬 |
1554 |
Requip*21cpr 0,25mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1555 |
Requip*21cpr 0,5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1556 |
Requip*21cpr 1mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1557 |
Requip*21cpr 5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1558 |
Requip*28cpr 8mg r.p. |
- |
- |
- |
- |
006 [1] 6 💬 |
1559 |
Requip-lp |
- |
- |
- |
- |
006 [1] 6 💬 |
1560 |
Requip-modutab |
- |
- |
- |
- |
006 [1] 6 💬 |
1561 |
Requip-modutab , 2mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1562 |
Requip-modutab , 4mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1563 |
Requip-modutab , 8mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1564 |
Requip-modutab, 2mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1565 |
Requip-modutab, 4mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1566 |
Requip-modutab, 8mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1567 |
Resistant maltodextrin |
Maltodextrin |
[1] D02329 D02329 💬 |
- |
- |
006 [1] 6 💬 |
1568 |
Resistant starch |
- |
- |
- |
- |
006 [1] 6 💬 |
1569 |
Restex tabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
1570 |
Rifampicin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 17, 46, 93, 299 💬 |
1571 |
Rifampin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 13, 84, 86, 299 💬 |
1572 |
Rifampin 300mg bid + istradefylline 40mg day 8 only |
Istradefylline |
[2] D00211 D00211, D04641 D04641 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1573 |
Rifaximin |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
006 [6] 6 , 65, 96, 97, 99, 296 💬 |
1574 |
Rifaximin 550 mg |
Rifaximin |
[1] D02554 D02554 💬 |
- |
- |
006 [1] 6 💬 |
1575 |
Ritalin |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1576 |
Riv-tds 13.3 mg/24 h |
- |
- |
- |
- |
006 [1] 6 💬 |
1577 |
Rivastigmin luye transdermal patches - 4.6mg/24h |
- |
- |
- |
- |
006 [1] 6 💬 |
1578 |
Rivastigmine |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
005 [3] 5 , 6 , 13 💬 |
1579 |
Rivastigmine capsule |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1580 |
Rivastigmine cf |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1581 |
Rivastigmine luye transdermal patch- 9.5mg/24h |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1582 |
Rivastigmine patch 9.5 cm2 |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1583 |
Rivastigmine transdermal patch |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [2] 6 , 13 💬 |
1584 |
Rivastigmine transdermal system |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1585 |
Rivastigmine transdermal system 13.3 mg/24 h |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
1586 |
Rm-131 |
- |
- |
- |
- |
006 [1] 6 💬 |
1587 |
Ro |
- |
- |
- |
- |
006 [1] 6 💬 |
1588 |
Ro7046015 |
- |
- |
- |
- |
006 [1] 6 💬 |
1589 |
Rop |
- |
- |
- |
- |
006 [1] 6 💬 |
1590 |
Rop+l-dopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1591 |
Ropinirole |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 309 💬 |
1592 |
Ropinirole (as hydrochloride) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1593 |
Ropinirole controlled-release (requip cr) for rls |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1594 |
Ropinirole cr 2mg tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1595 |
Ropinirole cr 8mg tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1596 |
Ropinirole hydrochloride |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 309 💬 |
1597 |
Ropinirole hydrochloride extended-release tablet |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1598 |
Ropinirole hydrochloride extended-release tablet placebo |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1599 |
Ropinirole hydrochloride prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1600 |
Ropinirole immediate release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1601 |
Ropinirole implant |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1602 |
Ropinirole ir |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1603 |
Ropinirole ir tablets |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1604 |
Ropinirole monotherapy |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1605 |
Ropinirole oral product |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1606 |
Ropinirole pr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1607 |
Ropinirole pr, 2mg |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1608 |
Ropinirole pr/xr |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1609 |
Ropinirole pr/xr tablets |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1610 |
Ropinirole prolonged release |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1611 |
Ropinirole prolonged release/extended release(pr/xr) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1612 |
Ropinirole xl |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1613 |
Ropinirole xl (formerly cr) |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1614 |
Ropinirole/l-dopa |
Levodopa |
[3] D00059 D00059, D00784 D00784, D08489 D08489 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1615 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
1616 |
Rotigotin |
- |
- |
- |
- |
006 [1] 6 💬 |
1617 |
Rotigotina |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1618 |
Rotigotine |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1619 |
Rotigotine (reference product pr 2.1.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1620 |
Rotigotine (test product pr 2.3.1) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1621 |
Rotigotine hydrochloride |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1622 |
Rotigotine nasal spray |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1623 |
Rotigotine transdermal patch |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1624 |
Rotigotine transdermal patch 2mg/24h(10cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1625 |
Rotigotine transdermal patch 4mg/24h (20cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1626 |
Rotigotine transdermal patch 6mg/24h (30cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1627 |
Rotigotine transdermal patch 8mg/24h (40cm2) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1628 |
Rotigotine tts (test) |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1629 |
Rotigotine, extended-release microspheres |
Rotigotine |
[1] D05768 D05768 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1630 |
Rozerem |
- |
- |
- |
- |
006 [1] 6 💬 |
1631 |
Rq-00000010 |
- |
- |
- |
- |
006 [1] 6 💬 |
1632 |
Rvg 08740 |
- |
- |
- |
- |
006 [1] 6 💬 |
1633 |
Rvg 55618 |
- |
- |
- |
- |
006 [1] 6 💬 |
1634 |
Rvt-101 35 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1635 |
Rytary 145 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1636 |
Rytary 195 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1637 |
S 90049 |
- |
- |
- |
- |
006 [1] 6 💬 |
1638 |
S 90049 - f36 |
- |
- |
- |
- |
006 [1] 6 💬 |
1639 |
S 90049 - f38 |
- |
- |
- |
- |
006 [1] 6 💬 |
1640 |
S.c. apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1641 |
S90049 |
- |
- |
- |
- |
006 [1] 6 💬 |
1642 |
Sa |
- |
- |
- |
- |
006 [5] 6 , 30, 60, 118, 298 💬 |
1643 |
Safety observation |
- |
- |
- |
- |
006 [1] 6 💬 |
1644 |
Safinamida |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1645 |
Safinamide |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
1646 |
Safinamide (as add-on therapy) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1647 |
Safinamide + levodopa |
Levodopa |
[2] D00059 D00059, D10158 D10158 💬 |
DRD1 [6] DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 |
Alcoholism [20] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1648 |
Safinamide metansolfonato |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1649 |
Safinamide metansolfonato (12 weeks) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1650 |
Safinamide methanesulfonate |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
1651 |
Safinamide methanesulfonate 100mg |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1652 |
Safinamide methanesulfonate 150mg |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1653 |
Safinamide methansulfonate |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1654 |
Safinamide, mao-b inhibitor |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1655 |
Safinimide 50-100 mg/day |
- |
- |
- |
- |
006 [1] 6 💬 |
1656 |
Sage |
Sage |
- |
- |
- |
006 [1] 6 💬 |
1657 |
Sage leaf |
Sage |
- |
- |
- |
006 [1] 6 💬 |
1658 |
Sage-217 |
- |
- |
- |
- |
006 [1] 6 💬 |
1659 |
Sage-718 |
- |
- |
- |
- |
006 [2] 6 , 8 💬 |
1660 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
1661 |
Saline intranasal delivery |
- |
- |
- |
- |
006 [1] 6 💬 |
1662 |
Sam |
- |
- |
- |
- |
006 [1] 6 💬 |
1663 |
Sam-e |
Ademetionine |
[1] D07128 D07128 💬 |
- |
- |
006 [1] 6 💬 |
1664 |
Sar402671, gz402671 or gz/sar402671 |
- |
- |
- |
- |
006 [3] 6 , 19, 67 💬 |
1665 |
Saracatinib |
Saracatinib |
[1] D09664 D09664 💬 |
ABL1 [2] ABL1, SRC 💬 |
Adherens junction [46] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
006 [3] 6 , 89, 272 💬 |
1666 |
Sarcosine |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
1667 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
1668 |
Sargramostim |
Sargramostim |
[1] D05803 D05803 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 [7] 6 , 28, 60, 62, 96, 229, 285 💬 |
1669 |
Sarizotan |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
1670 |
Sarizotan hc1 |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
1671 |
Sarizotan hcl |
Sarizotan |
- |
- |
- |
006 [1] 6 💬 |
1672 |
Sarizotan hydrochloride |
Sarizotan |
- |
- |
- |
006 [2] 6 , 156 💬 |
1673 |
Sch 420814 |
- |
- |
- |
- |
006 [1] 6 💬 |
1674 |
Sch 420814 10 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1675 |
Sch 420814 100 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1676 |
Sch 900800 |
- |
- |
- |
- |
006 [1] 6 💬 |
1677 |
Sch420814 |
- |
- |
- |
- |
006 [1] 6 💬 |
1678 |
Selegiline |
Selegiline |
[2] D00785 D00785, D03731 D03731 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1679 |
Selegiline hcl 5 pch |
Selegiline |
[2] D00785 D00785, D03731 D03731 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1680 |
Semaglutide |
Semaglutide |
[1] D10025 D10025 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [1] 6 💬 |
1681 |
Semi continuous intra-oral administration of ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
1682 |
Sep-363856 |
SEP-363856 |
- |
- |
- |
006 [1] 6 💬 |
1683 |
Ser-214 |
- |
- |
- |
- |
006 [1] 6 💬 |
1684 |
Serine |
Serine |
[1] D00016 D00016 💬 |
- |
- |
002 [3] 2 , 6 , 86 💬 |
1685 |
Seroquel |
- |
- |
- |
- |
006 [1] 6 💬 |
1686 |
Sertraline |
Sertraline |
[2] D00825 D00825, D02360 D02360 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 206 💬 |
1687 |
Sevoflurane |
Sevoflurane |
[1] D00547 D00547 💬 |
- |
- |
006 [6] 6 , 21, 22, 34, 98, 296 💬 |
1688 |
Sifol |
- |
- |
- |
- |
006 [1] 6 💬 |
1689 |
Sifrol |
- |
- |
- |
- |
006 [1] 6 💬 |
1690 |
Sifrol 0,088 |
- |
- |
- |
- |
006 [1] 6 💬 |
1691 |
Sifrol 0,18 |
- |
- |
- |
- |
006 [1] 6 💬 |
1692 |
Sifrol 0,35 |
- |
- |
- |
- |
006 [1] 6 💬 |
1693 |
Sifrol 0,7 |
- |
- |
- |
- |
006 [1] 6 💬 |
1694 |
Sifrol, 0,35 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
1695 |
Sifrol, 0,70 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
1696 |
Sifrol, mirapexin |
- |
- |
- |
- |
006 [1] 6 💬 |
1697 |
Sifrol® |
- |
- |
- |
- |
006 [1] 6 💬 |
1698 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
1699 |
Silicon |
Silicon |
- |
- |
- |
006 [1] 6 💬 |
1700 |
Silodosin |
Silodosin |
[1] D01965 D01965 💬 |
ADRA1A [1] ADRA1A 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1701 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
1702 |
Simvastatine |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [3] 6 , 13, 288 💬 |
1703 |
Sinemet |
- |
- |
- |
- |
006 [1] 6 💬 |
1704 |
Sinemet (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1705 |
Sinemet (comparator) |
- |
- |
- |
- |
006 [1] 6 💬 |
1706 |
Sinemet (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1707 |
Sinemet 10-100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1708 |
Sinemet 100 mg + 25 mg compresse |
- |
- |
- |
- |
006 [1] 6 💬 |
1709 |
Sinemet 125 |
- |
- |
- |
- |
006 [1] 6 💬 |
1710 |
Sinemet 125 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1711 |
Sinemet 200mg/50mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1712 |
Sinemet 25-100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1713 |
Sinemet 25/100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1714 |
Sinemet cr |
- |
- |
- |
- |
006 [1] 6 💬 |
1715 |
Sinemet cr 25mg-100mg extended-release tablet |
- |
- |
- |
- |
006 [1] 6 💬 |
1716 |
Sinemet ir |
- |
- |
- |
- |
006 [1] 6 💬 |
1717 |
Sinemet plus |
- |
- |
- |
- |
006 [1] 6 💬 |
1718 |
Sinemet plus (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1719 |
Sinemet*50cpr 100mg+25mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1720 |
Sinemet-plus tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1721 |
Sinemet® |
- |
- |
- |
- |
006 [1] 6 💬 |
1722 |
Sinemet® 100/25 |
- |
- |
- |
- |
006 [1] 6 💬 |
1723 |
Sinemet® 100/25 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1724 |
Sinemet® controlled release (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1725 |
Sinemet® cr |
- |
- |
- |
- |
006 [1] 6 💬 |
1726 |
Sinemet® cr 100/25 |
- |
- |
- |
- |
006 [1] 6 💬 |
1727 |
Sinemet® plus 25 mg/100 mg tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1728 |
Sinemet®-plus tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1729 |
Sinemet®25-100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1730 |
Sirio*30cpr eff 25mg+100mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1731 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
1732 |
Sitagliptin |
Sitagliptin |
[1] D08516 D08516 💬 |
DPP4 [1] DPP4 💬 |
Protein digestion and absorption [1] Protein digestion and absorption |
006 [4] 6 , 75, 233, 299 💬 |
1733 |
Sk&f101468 |
- |
- |
- |
- |
006 [1] 6 💬 |
1734 |
Skf-101468a |
- |
- |
- |
- |
006 [1] 6 💬 |
1735 |
Slv308 |
- |
- |
- |
- |
006 [1] 6 💬 |
1736 |
Slv308 (mono) hydro |
- |
- |
- |
- |
006 [1] 6 💬 |
1737 |
Slv308 (mono) hydrochlo |
- |
- |
- |
- |
006 [1] 6 💬 |
1738 |
Slv308 (mono) hydrochlori |
- |
- |
- |
- |
006 [1] 6 💬 |
1739 |
Slv308 (mono) hydrochloride |
- |
- |
- |
- |
006 [1] 6 💬 |
1740 |
Slv308 (mono)hydrochloride |
- |
- |
- |
- |
006 [1] 6 💬 |
1741 |
Slv308 hydrochloride |
- |
- |
- |
- |
006 [1] 6 💬 |
1742 |
Slv308(mono)hydrochloride |
- |
- |
- |
- |
006 [1] 6 💬 |
1743 |
Smilagenin |
Smilagenin |
- |
- |
- |
006 [1] 6 💬 |
1744 |
Snd 919 cl2 y |
- |
- |
- |
- |
006 [1] 6 💬 |
1745 |
Snd 919 cl2y |
- |
- |
- |
- |
006 [1] 6 💬 |
1746 |
Snn0031 |
- |
- |
- |
- |
006 [1] 6 💬 |
1747 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1748 |
Sodium oxybate |
Sodium oxybate |
[1] D05866 D05866 💬 |
- |
- |
006 [2] 6 , 149 💬 |
1749 |
Solifenacin |
Solifenacin |
[2] D01269 D01269, D08522 D08522 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 [2] 6 , 13 💬 |
1750 |
Solifenacin succinate (vesicare) |
Solifenacin |
[2] D01269 D01269, D08522 D08522 💬 |
CHRM3 [1] CHRM3 💬 |
Alzheimer disease [11] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 [1] 6 💬 |
1751 |
Soligen |
- |
- |
- |
- |
006 [1] 6 💬 |
1752 |
Solu-cortef |
- |
- |
- |
- |
006 [3] 6 , 81, 83 💬 |
1753 |
Solu-cortef, powder for solution for injection, 100mg, and 'act-o-vial' |
- |
- |
- |
- |
006 [1] 6 💬 |
1754 |
Sorbitol |
Sorbitol |
[1] D00096 D00096 💬 |
- |
- |
006 [2] 6 , 10 💬 |
1755 |
Soy protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1756 |
Spect |
- |
- |
- |
- |
006 [1] 6 💬 |
1757 |
Spheramine (bay86-5280) |
- |
- |
- |
- |
006 [1] 6 💬 |
1758 |
Spiropent |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1759 |
Spm 926 |
- |
- |
- |
- |
006 [1] 6 💬 |
1760 |
Spm 962 |
- |
- |
- |
- |
006 [1] 6 💬 |
1761 |
Spm962 |
- |
- |
- |
- |
006 [1] 6 💬 |
1762 |
Sqjz herbal mixtures |
- |
- |
- |
- |
006 [1] 6 💬 |
1763 |
Sr57667b |
- |
- |
- |
- |
006 [1] 6 💬 |
1764 |
Stalevo |
- |
- |
- |
- |
006 [1] 6 💬 |
1765 |
Stalevo (levodopa/ carbidopa/ entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1766 |
Stalevo (levodopa/carbidopa/entacapona) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1767 |
Stalevo (levodopa/carbidopa/entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1768 |
Stalevo 100 |
- |
- |
- |
- |
006 [1] 6 💬 |
1769 |
Stalevo 100 mg/ 25 mg/ 200 mg filmtabletten |
- |
- |
- |
- |
006 [1] 6 💬 |
1770 |
Stalevo 100 mg/25 mg / 200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1771 |
Stalevo 100/25/200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1772 |
Stalevo 150 |
- |
- |
- |
- |
006 [1] 6 💬 |
1773 |
Stalevo 150/37.5/200 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1774 |
Stalevo*100cpr 100/25/200mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1775 |
Stalevo*100cpr 50/12,5/200mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1776 |
Stalevo® |
- |
- |
- |
- |
006 [1] 6 💬 |
1777 |
Standard ld/cd |
- |
- |
- |
- |
006 [1] 6 💬 |
1778 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
1779 |
Stilnoct |
- |
- |
- |
- |
006 [1] 6 💬 |
1780 |
Strattera |
- |
- |
- |
- |
006 [1] 6 💬 |
1781 |
Study drug |
- |
- |
- |
- |
006 [2] 6 , 13 💬 |
1782 |
Subcutaneous apomorphine |
Apomorphine |
[2] D02004 D02004, D07460 D07460 💬 |
DRD1 [2] DRD1, DRD2 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1783 |
Subcutaneous hydrocortisone 10mg |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
1784 |
Subjects will undergo the 123-i ibvm imaging visit |
- |
- |
- |
- |
006 [1] 6 💬 |
1785 |
Sugar pill |
- |
- |
- |
- |
005 [8] 5 , 6 , 49, 67, 70, 86, 206, 210 💬 |
1786 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
1787 |
Sumanirole |
Sumanirole |
- |
- |
- |
006 [1] 6 💬 |
1788 |
Supplementation |
- |
- |
- |
- |
006 [1] 6 💬 |
1789 |
Supressi. t-diet plus range |
- |
- |
- |
- |
006 [1] 6 💬 |
1790 |
Suvorexant |
Suvorexant |
[1] D10082 D10082 💬 |
HCRTR1 [2] HCRTR1, HCRTR2 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
005 [3] 5 , 6 , 13 💬 |
1791 |
Syn115 |
- |
- |
- |
- |
006 [1] 6 💬 |
1792 |
Syn115 tablets, 60 mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1793 |
Syn120 |
- |
- |
- |
- |
006 [1] 6 💬 |
1794 |
Synthetic oxytocin |
Oxytocin |
[1] D00089 D00089 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1795 |
Syntocinon |
- |
- |
- |
- |
006 [3] 6 , 127, 193 💬 |
1796 |
Syntocinon 40 iu/ml nasal spray |
- |
- |
- |
- |
006 [1] 6 💬 |
1797 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1798 |
Tacrolimus tablets |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1799 |
Tadalafil |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
1800 |
Tak-071 |
- |
- |
- |
- |
006 [1] 6 💬 |
1801 |
Talampanel |
Talampanel |
[1] D02696 D02696 💬 |
GRIA1 [4] GRIA1, GRIA2, GRIA3, GRIA4 💬 |
Amphetamine addiction [16] Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [2] 2 , 6 💬 |
1802 |
Targinact 10 mg/5 mg prolonged-release tablets |
- |
- |
- |
- |
006 [2] 6 , 226 💬 |
1803 |
Targinact 20 mg/10 mg prolonged-release tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1804 |
Targinact 5 mg/2.5 mg prolonged-release tablets |
- |
- |
- |
- |
006 [1] 6 💬 |
1805 |
Tasmar |
- |
- |
- |
- |
006 [2] 6 , 28 💬 |
1806 |
Tavapadon |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1807 |
Tavapadon 0.25mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1808 |
Tavapadon 1mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1809 |
Tavapadon 5mg |
Tavapadon |
[1] D11431 D11431 💬 |
DRD1 [2] DRD1, DRD5 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway |
006 [1] 6 💬 |
1810 |
Tce |
- |
- |
- |
- |
006 [1] 6 💬 |
1811 |
Tch346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) |
Hydrogen |
- |
- |
- |
006 [1] 6 💬 |
1812 |
Td-9855 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
1813 |
Technetium (99mtc) exametazime |
Exametazime |
[1] D01109 D01109 💬 |
- |
- |
006 [1] 6 💬 |
1814 |
Terazosin |
Terazosin |
[2] D00610 D00610, D08569 D08569 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1815 |
Terazosin 5 mg |
Terazosin |
[2] D00610 D00610, D08569 D08569 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1816 |
Tesofensine |
Tesofensine |
- |
- |
- |
006 [2] 6 , 193 💬 |
1817 |
Thn02 |
- |
- |
- |
- |
006 [1] 6 💬 |
1818 |
Thn102 dosage a |
- |
- |
- |
- |
006 [1] 6 💬 |
1819 |
Thn102 dosage b |
- |
- |
- |
- |
006 [1] 6 💬 |
1820 |
Thn102 dosage c |
- |
- |
- |
- |
006 [1] 6 💬 |
1821 |
Tigan |
- |
- |
- |
- |
006 [1] 6 💬 |
1822 |
Tigan® |
- |
- |
- |
- |
006 [1] 6 💬 |
1823 |
To |
- |
- |
- |
- |
006 [1] 6 💬 |
1824 |
Tocovid suprabio |
- |
- |
- |
- |
006 [1] 6 💬 |
1825 |
Tolcapon |
Tolcapone |
[1] D00786 D00786 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1826 |
Tolcapone |
Tolcapone |
[1] D00786 D00786 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [3] 6 , 28, 127 💬 |
1827 |
Tolubuterol hydrochloride |
- |
- |
- |
- |
006 [1] 6 💬 |
1828 |
Topiramate |
Topiramate |
[1] D00537 D00537 💬 |
CA2 [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [52] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 140, 144, 156, 193 💬 |
1829 |
Topiramate (drug) |
Topiramate |
[1] D00537 D00537 💬 |
CA2 [36] CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [52] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1830 |
Toz |
- |
- |
- |
- |
006 [1] 6 💬 |
1831 |
Tozadenant |
Tozadenant |
[1] D10174 D10174 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1832 |
Tozadenant (syn115) 120 mg bid |
Tozadenant |
[1] D10174 D10174 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1833 |
Tozadenant (syn115) 180 mg bid |
Tozadenant |
[1] D10174 D10174 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1834 |
Tozadenant (syn115) 240 mg bid |
Tozadenant |
[1] D10174 D10174 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1835 |
Tozadenant (syn115) 60 mg bid |
Tozadenant |
[1] D10174 D10174 💬 |
ADORA2A [1] ADORA2A 💬 |
Alcoholism [7] Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway |
006 [1] 6 💬 |
1836 |
Traditional chinese medicinal mixture (composed of roucongrong and adjuvant) |
- |
- |
- |
- |
006 [1] 6 💬 |
1837 |
Transdermal flumazenil (added 4/2020) |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1838 |
Transdermal nicotine |
Nicotine |
[3] D03365 D03365, D05156 D05156, D05157 D05157 💬 |
CHRNA1 [16] CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 |
Alzheimer disease [7] Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases |
006 [1] 6 💬 |
1839 |
Trigel |
- |
- |
- |
- |
006 [1] 6 💬 |
1840 |
Trihexyphenidyl |
Trihexyphenidyl |
[2] D00787 D00787, D08638 D08638 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
005 [2] 5 , 6 💬 |
1841 |
Trimethobenzamide |
Trimethobenzamide |
[2] D02733 D02733, D08643 D08643 💬 |
- |
- |
006 [1] 6 💬 |
1842 |
Trimethobenzamide hydrochloride |
Trimethobenzamide |
[2] D02733 D02733, D08643 D08643 💬 |
- |
- |
006 [1] 6 💬 |
1843 |
Trivastal |
- |
- |
- |
- |
006 [1] 6 💬 |
1844 |
Tropicamide |
Tropicamide |
[1] D00397 D00397 💬 |
CHRM1 [5] CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 19 💬 |
1845 |
Tryptophan |
Tryptophan |
[1] D00020 D00020 💬 |
- |
- |
006 [1] 6 💬 |
1846 |
Tryptophan (trp) depletion |
Tryptophan |
[1] D00020 D00020 💬 |
- |
- |
006 [1] 6 💬 |
1847 |
Tulobuterol |
Tulobuterol |
[1] D02151 D02151 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1848 |
Tulobuterol hydrochloride |
Tulobuterol |
[1] D02151 D02151 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1849 |
Tvp-1012 |
- |
- |
- |
- |
006 [1] 6 💬 |
1850 |
Tvp-1012 (1 mg/day) with levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
1851 |
Tvp-1012 0.5mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1852 |
Tvp-1012 1mg |
- |
- |
- |
- |
006 [1] 6 💬 |
1853 |
Tyramine |
Tyramine |
- |
- |
- |
006 [1] 6 💬 |
1854 |
Tyrosine |
Tyrosine |
[1] D00022 D00022 💬 |
- |
- |
006 [3] 6 , 86, 111 💬 |
1855 |
Ub-312 |
- |
- |
- |
- |
006 [1] 6 💬 |
1856 |
Ubiquinol |
Ubiquinol |
- |
- |
- |
006 [3] 6 , 8 , 17 💬 |
1857 |
Ucb0599 |
- |
- |
- |
- |
006 [1] 6 💬 |
1858 |
Ucb7853 |
- |
- |
- |
- |
006 [1] 6 💬 |
1859 |
Urate |
Uric acid |
- |
- |
- |
006 [1] 6 💬 |
1860 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
006 [8] 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
1861 |
Ursonorm |
- |
- |
- |
- |
006 [1] 6 💬 |
1862 |
Usual dopaminergic per os treatment |
- |
- |
- |
- |
006 [1] 6 💬 |
1863 |
V1512 |
- |
- |
- |
- |
006 [1] 6 💬 |
1864 |
V1512 and entacapone |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [1] 6 💬 |
1865 |
V81444 |
- |
- |
- |
- |
006 [1] 6 💬 |
1866 |
Valerian |
Valerian |
- |
- |
- |
006 [1] 6 💬 |
1867 |
Varenicline |
Varenicline |
[1] D08669 D08669 💬 |
CHRNA4 [2] CHRNA4, CHRNB2 💬 |
Cholinergic synapse [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 [2] 6 , 18 💬 |
1868 |
Varenicline tartrate |
Varenicline |
[1] D08669 D08669 💬 |
CHRNA4 [2] CHRNA4, CHRNB2 💬 |
Cholinergic synapse [3] Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction |
006 [1] 6 💬 |
1869 |
Variation of behaviors of parkinson's disease |
- |
- |
- |
- |
006 [1] 6 💬 |
1870 |
Vehicle |
- |
- |
- |
- |
006 [4] 6 , 36, 160, 192 💬 |
1871 |
Venglustat |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [3] 6 , 19, 67 💬 |
1872 |
Venglustat malate |
Venglustat |
[1] D11633 D11633 💬 |
UGCG [1] UGCG 💬 |
Metabolic pathways [2] Metabolic pathways, Sphingolipid metabolism |
006 [1] 6 💬 |
1873 |
Venlafaxine |
Venlafaxine |
[2] D00821 D00821, D08670 D08670 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [3] 6 , 13, 46 💬 |
1874 |
Vineuro |
- |
- |
- |
- |
006 [1] 6 💬 |
1875 |
Vitamin b12 |
Cyanocobalamin |
[4] D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
006 [4] 6 , 201, 229, 299 💬 |
1876 |
Vitamin b12 supplementation |
Cyanocobalamin |
[4] D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
006 [1] 6 💬 |
1877 |
Vitamin b6 |
Pyridoxine |
[2] D02179 D02179, D08454 D08454 💬 |
- |
- |
006 [1] 6 💬 |
1878 |
Vitamin d3 |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [11] 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1879 |
Vitamin d3 - high dose |
Cholecalciferol |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 [1] 6 💬 |
1880 |
Vitamin e |
Vitamin E |
[1] D02331 D02331 💬 |
- |
- |
002 [11] 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1881 |
Viusid/alzer |
- |
- |
- |
- |
006 [1] 6 💬 |
1882 |
Vortioxetine |
Vortioxetine |
[1] D10184 D10184 💬 |
HTR1A [7] HTR1A, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E, SLC6A4 💬 |
Neuroactive ligand-receptor interaction [5] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1883 |
Vr040 |
- |
- |
- |
- |
006 [1] 6 💬 |
1884 |
Vr040/aspirair® inhaler |
- |
- |
- |
- |
006 [1] 6 💬 |
1885 |
Vy-aadc01 |
- |
- |
- |
- |
006 [1] 6 💬 |
1886 |
Vy-aadc02 |
- |
- |
- |
- |
006 [1] 6 💬 |
1887 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1888 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1889 |
Wd-1603 |
- |
- |
- |
- |
006 [1] 6 💬 |
1890 |
Wd-1603 carbidopa and levodopa extended-release tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1891 |
Wd-1603 carbidopa/levodopa extended-release tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
1892 |
Whey protein |
- |
- |
- |
- |
006 [2] 6 , 96 💬 |
1893 |
White chocolate (0% cocoa) |
Cocoa |
- |
- |
- |
006 [1] 6 💬 |
1894 |
Win-1001x |
- |
- |
- |
- |
006 [1] 6 💬 |
1895 |
Wuling powder |
- |
- |
- |
- |
006 [1] 6 💬 |
1896 |
Xadago |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
1897 |
Xadago (safinamide) |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1898 |
Xc130-a10h |
- |
- |
- |
- |
006 [1] 6 💬 |
1899 |
Xeomin |
- |
- |
- |
- |
005 [7] 5 , 6 , 7 , 13, 15, 17, 113 💬 |
1900 |
Xiaoyao pill |
- |
- |
- |
- |
006 [1] 6 💬 |
1901 |
Xp21279 |
- |
- |
- |
- |
006 [1] 6 💬 |
1902 |
Xp21279 and carbidopa (experimental) |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
1903 |
Yohimbine |
Yohimbine |
[1] D08685 D08685 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1904 |
Yohimbine hcl |
Yohimbine |
[1] D08685 D08685 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
1905 |
Zelapar |
- |
- |
- |
- |
006 [1] 6 💬 |
1906 |
Zoledronic acid |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [9] 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |
1907 |
Zoledronic acid 5mg/bag 100ml inj |
Zoledronic acid |
[4] D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [1] 6 💬 |
1908 |
Zolmitriptan |
Zolmitriptan |
[1] D00415 D00415 💬 |
HTR1B [2] HTR1B, HTR1D 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [1] 6 💬 |
1909 |
Zolpidem |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
005 [3] 5 , 6 , 46 💬 |
1910 |
Zolpidem first dose |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1911 |
Zolpidem second dose |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1912 |
Zolpidem tartrate |
Zolpidem |
[2] D00706 D00706, D08690 D08690 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |
1913 |
Zonegran |
- |
- |
- |
- |
006 [1] 6 💬 |
1914 |
Zonisamide |
Zonisamide |
[1] D00538 D00538 💬 |
CACNA1G [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 [1] 6 💬 |
1915 |
Zonisamide capsules |
Zonisamide |
[1] D00538 D00538 💬 |
CACNA1G [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 [1] 6 💬 |
1916 |
Zopiclone |
Zopiclone |
[1] D01372 D01372 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [1] 6 💬 |